repository,study_title,disease_diagnosis,study_group_description,sequences,lab_name,tissue,pcr_target_locus,cell_subset,cell_phenotype,pub_ids,study_id,subject_id,sample_id,template_class,sequencing_platform,repertoire_id,repertoire_name,repertoire_description,study_type,study_type_id,study_description,inclusion_exclusion_criteria,grants,collected_by,lab_address,submitted_by,keywords_study,synthetic,species,species_id,organism,organism_id,sex,age,age_min,age_max,age_unit,age_unit_id,age_event,ancestry_population,ethnicity,race,strain_name,linked_subjects,link_type,disease_diagnosis_id,disease_length,disease_stage,prior_therapies,immunogen,intervention,medical_history,sample_processing_id,sample_type,tissue_id,anatomic_site,disease_state_sample,collection_time_point_relative,collection_time_point_reference,biomaterial_provider,tissue_processing,cell_subset_id,cell_species,cell_species_id,single_cell,cell_number,cells_per_reaction,cell_storage,cell_quality,cell_isolation,cell_processing_protocol,template_quality,template_amount,library_generation_method,library_generation_protocol,library_generation_kit_version,forward_pcr_primer_target_location,reverse_pcr_primer_target_location,complete_sequences,physical_linkage,sequencing_run_id,total_reads_passing_qc_filter,sequencing_facility,sequencing_run_date,sequencing_kit,file_type,filename,read_direction,read_length,paired_filename,paired_read_direction,paired_read_length,data_processing_id,primary_annotation,software_versions,paired_reads_assembly,quality_thresholds,primer_match_cutoffs,collapsing_method,data_processing_protocols,data_processing_files,germline_database,analysis_provenance_id
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,617111,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000014,ADIR0000014_TCRB,DNA,Illumina,5f4c16a983a8226b3dd8db57, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,43,43,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , ,"IgA Nephropathy, Coronary artery disease",5f4c16a983a8226b3dd8db57,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,45 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,617111,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16a983a8226b3dd8db57,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIR0000014_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,868205,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000086,ADIR0000086_TCRB,DNA,Illumina,5f4c16ab83a8226b3dd8db59, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,35,35,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , , ,5f4c16ab83a8226b3dd8db59,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,48 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,868205,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ab83a8226b3dd8db59,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIR0000086_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,366964,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000093,ADIR0000093_TCRB,DNA,Illumina,5f4c16ad83a8226b3dd8db5a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,38,38,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f4c16ad83a8226b3dd8db5a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,10 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,366964,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ad83a8226b3dd8db5a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIR0000093_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,791145,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000023,ADIRP0000023_TCRB,DNA,Illumina,5f4c16ae83a8226b3dd8db5b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,31,31,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,20 d,Recovered, , , , ,5f4c16ae83a8226b3dd8db5b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,62 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,791145,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ae83a8226b3dd8db5b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000023_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,855812,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000036,ADIRP0000036_TCRB,DNA,Illumina,5f4c16af83a8226b3dd8db5c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,32,32,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , , ,5f4c16af83a8226b3dd8db5c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,62 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,855812,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16af83a8226b3dd8db5c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000036_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,580604,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000045,ADIRP0000045_TCRB,DNA,Illumina,5f4c16b083a8226b3dd8db5d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,27,27,year,UO:0000036,Sample Collection, , ,Middle Eastern, , , ,DOID:0080600,21 d,Recovered, , , , ,5f4c16b083a8226b3dd8db5d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,53 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,580604,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16b083a8226b3dd8db5d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000045_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,721300,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000052,ADIRP0000052_TCRB,DNA,Illumina,5f4c16b183a8226b3dd8db5e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,40,40,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,15 d,Recovered, , , , ,5f4c16b183a8226b3dd8db5e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,16 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,721300,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16b183a8226b3dd8db5e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000052_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1043516,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000057,ADIRP0000057_TCRB,DNA,Illumina,5f4c16b283a8226b3dd8db5f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,49,49,year,UO:0000036,Sample Collection, , ,Mixed racial group, , , ,DOID:0080600, ,Acute, , , ,Asthma,5f4c16b283a8226b3dd8db5f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,30 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1043516,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16b283a8226b3dd8db5f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000057_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,548708,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000066,ADIRP0000066_TCRB,DNA,Illumina,5f4c16b383a8226b3dd8db60, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,22,22,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,10 d,Recovered, , , , ,5f4c16b383a8226b3dd8db60,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,62 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,548708,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16b383a8226b3dd8db60,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000066_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,613822,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000067,ADIRP0000067_TCRB,DNA,Illumina,5f4c16b383a8226b3dd8db61, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,33,33,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,40 d,Recovered, , , , ,5f4c16b383a8226b3dd8db61,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,37 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,613822,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16b383a8226b3dd8db61,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000067_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,819078,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000106,ADIRP0000106_TCRB,DNA,Illumina,5f4c16b583a8226b3dd8db63, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,41,41,year,UO:0000036,Sample Collection, , ,Hispanic, , , ,DOID:0080600,28 d,Recovered, , , ,"Hypothyroidism, Asthma",5f4c16b583a8226b3dd8db63,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,43 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,819078,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16b583a8226b3dd8db63,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000106_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,966188,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000117,ADIRP0000117_TCRB,DNA,Illumina,5f4c16b783a8226b3dd8db65, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,47,47,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute,Plaquenil - prednisone, , ,"Juvenile rheumatoid arthritis, Temporal lobe epilepsy, Asthma",5f4c16b783a8226b3dd8db65,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,19 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,966188,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16b783a8226b3dd8db65,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000117_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1196398,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000120,ADIRP0000120_TCRB,DNA,Illumina,5f4c16b883a8226b3dd8db66, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,23,23,year,UO:0000036,Sample Collection, , ,Black or African American, , , ,DOID:0080600,7 d,Recovered, , , , ,5f4c16b883a8226b3dd8db66,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,33 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1196398,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16b883a8226b3dd8db66,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000120_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,649670,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000129,ADIRP0000129_TCRB,DNA,Illumina,5f4c16b983a8226b3dd8db67, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,38,38,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered,Imuran, , ,"Dermatomyocititis- morphea, Crohn's disease, Rheumatoid arthritis, Scleroder",5f4c16b983a8226b3dd8db67,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,56 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,649670,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16b983a8226b3dd8db67,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000129_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,42576,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000137,ADIRP0000137_TCRB,DNA,Illumina,5f4c16ba83a8226b3dd8db68, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,33,33,year,UO:0000036,Sample Collection, , ,Mixed racial group, , , ,DOID:0080600,4 d,Recovered, , , , ,5f4c16ba83a8226b3dd8db68,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,43 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,42576,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ba83a8226b3dd8db68,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000137_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,901858,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000141,ADIRP0000141_TCRB,DNA,Illumina,5f4c16bb83a8226b3dd8db69, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,29,29,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,10 d,Recovered, , , ,Asthma,5f4c16bb83a8226b3dd8db69,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,42 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,901858,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16bb83a8226b3dd8db69,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000141_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,600708,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000174,ADIRP0000174_TCRB,DNA,Illumina,5f4c16bc83a8226b3dd8db6a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,41,41,year,UO:0000036,Sample Collection, , ,Middle Eastern European, , , ,DOID:0080600,11 d,Recovered, , , , ,5f4c16bc83a8226b3dd8db6a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,30 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,600708,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16bc83a8226b3dd8db6a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000174_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,601841,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000190,ADIRP0000190_TCRB,DNA,Illumina,5f4c16bd83a8226b3dd8db6c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,37,37,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,8 d,Recovered, , , ,Papillary Thyroid Cancer (recovered),5f4c16bd83a8226b3dd8db6c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,75 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,601841,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16bd83a8226b3dd8db6c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000190_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,810630,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000247,ADIRP0000247_TCRB,DNA,Illumina,5f4c16be83a8226b3dd8db6d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,58,58,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,7 d,Recovered, , , , ,5f4c16be83a8226b3dd8db6d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,62 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,810630,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16be83a8226b3dd8db6d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000247_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,306716,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000251,ADIRP0000251_TCRB,DNA,Illumina,5f4c16bf83a8226b3dd8db6e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,56,56,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,15 d,Recovered, , , ,Heart disease,5f4c16bf83a8226b3dd8db6e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,92 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,306716,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16bf83a8226b3dd8db6e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000251_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1047920,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000252,ADIRP0000252_TCRB,DNA,Illumina,5f4c16c083a8226b3dd8db6f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,28,28,year,UO:0000036,Sample Collection, , ,Asian or Pacific Islander, , , ,DOID:0080600,14 d,Recovered, , , , ,5f4c16c083a8226b3dd8db6f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,48 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1047920,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16c083a8226b3dd8db6f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000252_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1110928,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000289,ADIRP0000289_TCRB,DNA,Illumina,5f4c16c283a8226b3dd8db71, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,28,28,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f4c16c283a8226b3dd8db71,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,55 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1110928,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16c283a8226b3dd8db71,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000289_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,710635,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000292,ADIRP0000292_TCRB,DNA,Illumina,5f4c16c383a8226b3dd8db72, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,55,55,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , , ,5f4c16c383a8226b3dd8db72,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,50 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,710635,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16c383a8226b3dd8db72,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000292_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,572133,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000341,ADIRP0000341_TCRB,DNA,Illumina,5f4c16c483a8226b3dd8db73, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,66,66,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , , ,5f4c16c483a8226b3dd8db73,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,60 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,572133,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16c483a8226b3dd8db73,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000341_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,413296,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000342,ADIRP0000342_TCRB,DNA,Illumina,5f4c16c583a8226b3dd8db74, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,59,59,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , , ,5f4c16c583a8226b3dd8db74,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,14 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,413296,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16c583a8226b3dd8db74,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000342_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,892792,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000347,ADIRP0000347_TCRB,DNA,Illumina,5f4c16c683a8226b3dd8db75, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,37,37,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,8 d,Recovered, , , , ,5f4c16c683a8226b3dd8db75,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,32 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,892792,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16c683a8226b3dd8db75,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000347_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,285112,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000355,ADIRP0000355_TCRB,DNA,Illumina,5f4c16c783a8226b3dd8db77, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,54,54,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , ,"Facial skin cancer, Asthma",5f4c16c783a8226b3dd8db77,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,54 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,285112,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16c783a8226b3dd8db77,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000355_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,899701,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000356,ADIRP0000356_TCRB,DNA,Illumina,5f4c16c883a8226b3dd8db78, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,23,23,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , ,Asthma,5f4c16c883a8226b3dd8db78,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,44 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,899701,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16c883a8226b3dd8db78,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000356_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1026076,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000357,ADIRP0000357_TCRB,DNA,Illumina,5f4c16c983a8226b3dd8db79, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,24,24,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered,Goldbond Psoriasis Cream, , ,"Psoriasis, Asthma",5f4c16c983a8226b3dd8db79,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,44 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1026076,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16c983a8226b3dd8db79,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000357_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1031079,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000362,ADIRP0000362_TCRB,DNA,Illumina,5f4c16ca83a8226b3dd8db7a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,51,51,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , ,"Multiple sclerosis, Pre diabetic",5f4c16ca83a8226b3dd8db7a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,39 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1031079,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ca83a8226b3dd8db7a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000362_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,979588,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000376,ADIRP0000376_TCRB,DNA,Illumina,5f4c16cb83a8226b3dd8db7b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,35,35,year,UO:0000036,Sample Collection, , ,Indian- Irish- French- polish, , , ,DOID:0080600,15 d,Recovered, , , , ,5f4c16cb83a8226b3dd8db7b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,67 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,979588,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16cb83a8226b3dd8db7b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000376_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,748720,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000387,ADIRP0000387_TCRB,DNA,Illumina,5f4c16cc83a8226b3dd8db7c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,60,60,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,4 d,Recovered, , , ,Hypertension,5f4c16cc83a8226b3dd8db7c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,38 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,748720,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16cc83a8226b3dd8db7c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000387_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,764789,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000392,ADIRP0000392_TCRB,DNA,Illumina,5f4c16cc83a8226b3dd8db7d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,48,48,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , , ,5f4c16cc83a8226b3dd8db7d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,62 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,764789,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16cc83a8226b3dd8db7d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000392_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,680523,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000422,ADIRP0000422_TCRB,DNA,Illumina,5f4c16cd83a8226b3dd8db7e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,27,27,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute,"Inhaler, Albuterol", , , ,5f4c16cd83a8226b3dd8db7e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,58 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,680523,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16cd83a8226b3dd8db7e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000422_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,645783,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000423,ADIRP0000423_TCRB,DNA,Illumina,5f4c16ce83a8226b3dd8db7f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,32,32,year,UO:0000036,Sample Collection, , ,Asian or Pacific Islander, , , ,DOID:0080600, ,Recovered, , , , ,5f4c16ce83a8226b3dd8db7f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,49 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,645783,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ce83a8226b3dd8db7f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000423_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,674338,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000439,ADIRP0000439_TCRB,DNA,Illumina,5f4c16cf83a8226b3dd8db80, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,29,29,year,UO:0000036,Sample Collection, , ,Asian or Pacific Islander, , , ,DOID:0080600, ,Acute, , , , ,5f4c16cf83a8226b3dd8db80,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,13 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,674338,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16cf83a8226b3dd8db80,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000439_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,662793,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000499,ADIRP0000499_TCRB,DNA,Illumina,5f4c16d083a8226b3dd8db82, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,56,56,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,10 d,Recovered, , , ,Asthma,5f4c16d083a8226b3dd8db82,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,41 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,662793,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16d083a8226b3dd8db82,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000499_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,947304,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000511,ADIRP0000511_TCRB,DNA,Illumina,5f4c16d183a8226b3dd8db83, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,29,29,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,21 d,Recovered, , , , ,5f4c16d183a8226b3dd8db83,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,11 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,947304,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16d183a8226b3dd8db83,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000511_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,725254,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000539,ADIRP0000539_TCRB,DNA,Illumina,5f4c16d283a8226b3dd8db84, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,43,43,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,3 d,Recovered, , , ,Hashimoto's thyroiditis,5f4c16d283a8226b3dd8db84,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,57 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,725254,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16d283a8226b3dd8db84,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000539_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,765042,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000555,ADIRP0000555_TCRB,DNA,Illumina,5f4c16d383a8226b3dd8db85, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,48,48,year,UO:0000036,Sample Collection, , , , , , ,DOID:0080600,14 d,Recovered, , , , ,5f4c16d383a8226b3dd8db85,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,51 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,765042,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16d383a8226b3dd8db85,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000555_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,409185,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000570,ADIRP0000570_TCRB,DNA,Illumina,5f4c16d483a8226b3dd8db86, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,65,65,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,14 d,Recovered, , , , ,5f4c16d483a8226b3dd8db86,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,50 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,409185,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16d483a8226b3dd8db86,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000570_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,984502,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000618,ADIRP0000618_TCRB,DNA,Illumina,5f4c16d583a8226b3dd8db87, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,31,31,year,UO:0000036,Sample Collection, , ,Mixed racial group, , , ,DOID:0080600, ,Acute, , , ,"Rheumatoid arthritis, Asthma",5f4c16d583a8226b3dd8db87,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,29 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,984502,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16d583a8226b3dd8db87,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000618_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1152643,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000623,ADIRP0000623_TCRB,DNA,Illumina,5f4c16d583a8226b3dd8db88, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,59,59,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,20 d,Recovered, , , ,Asthma,5f4c16d583a8226b3dd8db88,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,34 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1152643,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16d583a8226b3dd8db88,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000623_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,650861,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000709,ADIRP0000709_TCRB,DNA,Illumina,5f4c16d783a8226b3dd8db8a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,41,41,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , ,Ulcerative colitis,5f4c16d783a8226b3dd8db8a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,30 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,650861,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16d783a8226b3dd8db8a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000709_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,594037,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000710,ADIRP0000710_TCRB,DNA,Illumina,5f4c16d883a8226b3dd8db8b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,36,36,year,UO:0000036,Sample Collection, , ,Hispanic, , , ,DOID:0080600,30 d,Recovered, , , , ,5f4c16d883a8226b3dd8db8b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,63 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,594037,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16d883a8226b3dd8db8b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000710_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,833555,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000730,ADIRP0000730_TCRB,DNA,Illumina,5f4c16d983a8226b3dd8db8c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,54,54,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute,Prednisone, , ,Hypertension,5f4c16d983a8226b3dd8db8c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,63 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,833555,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16d983a8226b3dd8db8c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000730_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,674035,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000752,ADIRP0000752_TCRB,DNA,Illumina,5f4c16db83a8226b3dd8db8e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,40,40,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , ,Asthma,5f4c16db83a8226b3dd8db8e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,52 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,674035,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16db83a8226b3dd8db8e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000752_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,503659,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000837,ADIRP0000837_TCRB,DNA,Illumina,5f4c16dc83a8226b3dd8db90, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,55,55,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,22 d,Recovered, , , , ,5f4c16dc83a8226b3dd8db90,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,50 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,503659,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16dc83a8226b3dd8db90,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000837_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,475090,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000868,ADIRP0000868_TCRB,DNA,Illumina,5f4c16dd83a8226b3dd8db91, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,58,58,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,16 d,Recovered, , , ,Hashimoto's thyroiditis,5f4c16dd83a8226b3dd8db91,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,61 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,475090,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16dd83a8226b3dd8db91,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000868_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,935205,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000875,ADIRP0000875_TCRB,DNA,Illumina,5f4c16de83a8226b3dd8db92, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,36,36,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , ,Asthma,5f4c16de83a8226b3dd8db92,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,41 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,935205,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16de83a8226b3dd8db92,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000875_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,113461,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000895,ADIRP0000895_TCRB,DNA,Illumina,5f4c16df83a8226b3dd8db93, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,52,52,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,28 d,Recovered, , , ,Hashimoto's thyroiditis,5f4c16df83a8226b3dd8db93,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,92 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,113461,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16df83a8226b3dd8db93,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000895_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,371804,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000919,ADIRP0000919_TCRB,DNA,Illumina,5f4c16e083a8226b3dd8db95, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,55,55,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , ,"Hypertension, ",5f4c16e083a8226b3dd8db95,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,57 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,371804,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16e083a8226b3dd8db95,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000919_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,848819,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000923,ADIRP0000923_TCRB,DNA,Illumina,5f4c16e183a8226b3dd8db96, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,34,34,year,UO:0000036,Sample Collection, , ,Mixed racial group, , , ,DOID:0080600, ,Acute, , , ,Diabetes (Type 2),5f4c16e183a8226b3dd8db96,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,20 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,848819,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16e183a8226b3dd8db96,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000923_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,491912,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000975,ADIRP0000975_TCRB,DNA,Illumina,5f4c16e383a8226b3dd8db98, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,49,49,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , ,"Asthma, Diabetes (Type 2), Hypertension",5f4c16e383a8226b3dd8db98,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,15 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,491912,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16e383a8226b3dd8db98,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0000975_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,881946,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001063,ADIRP0001063_TCRB,DNA,Illumina,5f4c16e583a8226b3dd8db9a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,47,47,year,UO:0000036,Sample Collection, , ,Black or African American, , , ,DOID:0080600,6 d,Recovered, , , , ,5f4c16e583a8226b3dd8db9a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,38 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,881946,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16e583a8226b3dd8db9a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001063_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,416717,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001066,ADIRP0001066_TCRB,DNA,Illumina,5f4c16e583a8226b3dd8db9b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,18,18,year,UO:0000036,Sample Collection, , ,Hispanic, , , ,DOID:0080600, ,Acute, , , , ,5f4c16e583a8226b3dd8db9b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,20 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,416717,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16e583a8226b3dd8db9b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001066_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,802358,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001070,ADIRP0001070_TCRB,DNA,Illumina,5f4c16e683a8226b3dd8db9c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,51,51,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , ,GERD - Barretts esophagus,5f4c16e683a8226b3dd8db9c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,20 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,802358,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16e683a8226b3dd8db9c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001070_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,712008,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001079,ADIRP0001079_TCRB,DNA,Illumina,5f4c16e783a8226b3dd8db9d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,60,60,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , , ,5f4c16e783a8226b3dd8db9d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,26 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,712008,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16e783a8226b3dd8db9d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001079_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,188558,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001104,ADIRP0001104_TCRB,DNA,Illumina,5f4c16e883a8226b3dd8db9e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,54,54,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute,Prednisone, , ,Asthma,5f4c16e883a8226b3dd8db9e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,76 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,188558,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16e883a8226b3dd8db9e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001104_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,637695,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001110,ADIRP0001110_TCRB,DNA,Illumina,5f4c16e983a8226b3dd8db9f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,40,40,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , ,"Rheumatoid arthritis, Asthma",5f4c16e983a8226b3dd8db9f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,56 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,637695,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16e983a8226b3dd8db9f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001110_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,837240,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001121,ADIRP0001121_TCRB,DNA,Illumina,5f4c16ea83a8226b3dd8dba0, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,61,61,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,3 d,Recovered, , , ,"Psoriasis, Asthma",5f4c16ea83a8226b3dd8dba0,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,38 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,837240,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ea83a8226b3dd8dba0,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001121_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,900907,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001145,ADIRP0001145_TCRB,DNA,Illumina,5f4c16ea83a8226b3dd8dba1, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,43,43,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,8 d,Recovered, , , , ,5f4c16ea83a8226b3dd8dba1,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,69 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,900907,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ea83a8226b3dd8dba1,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001145_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,715832,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001152,ADIRP0001152_TCRB,DNA,Illumina,5f4c16ec83a8226b3dd8dba2, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,24,24,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , , ,5f4c16ec83a8226b3dd8dba2,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,25 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,715832,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ec83a8226b3dd8dba2,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001152_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,779860,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001163,ADIRP0001163_TCRB,DNA,Illumina,5f4c16ec83a8226b3dd8dba3, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,51,51,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , ,"Asthma, Hypertension",5f4c16ec83a8226b3dd8dba3,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,26 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,779860,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ec83a8226b3dd8dba3,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001163_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,668883,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001185,ADIRP0001185_TCRB,DNA,Illumina,5f4c16ed83a8226b3dd8dba4, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,44,44,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute,Recently stopped Flovent HFA , , ,"Crohn's disease, Asthma",5f4c16ed83a8226b3dd8dba4,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,38 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,668883,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ed83a8226b3dd8dba4,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001185_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,633753,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001202,ADIRP0001202_TCRB,DNA,Illumina,5f4c16ee83a8226b3dd8dba5, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,54,54,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,20 d,Recovered, , , , ,5f4c16ee83a8226b3dd8dba5,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,47 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,633753,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ee83a8226b3dd8dba5,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001202_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,488754,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001207,ADIRP0001207_TCRB,DNA,Illumina,5f4c16ef83a8226b3dd8dba6, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,49,49,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,60 d,Recovered, , , , ,5f4c16ef83a8226b3dd8dba6,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,77 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,488754,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ef83a8226b3dd8dba6,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001207_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,585150,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001215,ADIRP0001215_TCRB,DNA,Illumina,5f4c16ef83a8226b3dd8dba7, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,56,56,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,14 d,Recovered, , , ,"Diabetes (Type 2), Hypertension, ",5f4c16ef83a8226b3dd8dba7,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,91 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,585150,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ef83a8226b3dd8dba7,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001215_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,474065,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001217,ADIRP0001217_TCRB,DNA,Illumina,5f4c16f083a8226b3dd8dba8, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,59,59,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,5 d,Recovered, , , ,"Congenital pulmonary stenosis, Valvotomy (1971)",5f4c16f083a8226b3dd8dba8,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,37 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,474065,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16f083a8226b3dd8dba8,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001217_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,655678,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001234,ADIRP0001234_TCRB,DNA,Illumina,5f4c16f283a8226b3dd8dbaa, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,37,37,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f4c16f283a8226b3dd8dbaa,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,74 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,655678,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16f283a8226b3dd8dbaa,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001234_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,594534,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001268,ADIRP0001268_TCRB,DNA,Illumina,5f4c16f483a8226b3dd8dbac, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,23,23,year,UO:0000036,Sample Collection, , ,Mixed racial group, , , ,DOID:0080600,1 d,Recovered, , , , ,5f4c16f483a8226b3dd8dbac,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,10 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,594534,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16f483a8226b3dd8dbac,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001268_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,815574,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001278,ADIRP0001278_TCRB,DNA,Illumina,5f4c16f583a8226b3dd8dbad, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,34,34,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,15 d,Recovered, , , ,Diabetes (Type 1),5f4c16f583a8226b3dd8dbad,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,18 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,815574,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16f583a8226b3dd8dbad,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001278_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,204226,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001296,ADIRP0001296_TCRB,DNA,Illumina,5f4c16f683a8226b3dd8dbaf, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,49,49,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,14 d,Recovered,Levothyroxine, , ,Graves disease,5f4c16f683a8226b3dd8dbaf,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,83 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,204226,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16f683a8226b3dd8dbaf,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001296_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,605169,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001311,ADIRP0001311_TCRB,DNA,Illumina,5f4c16f783a8226b3dd8dbb0, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,36,36,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f4c16f783a8226b3dd8dbb0,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,20 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,605169,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16f783a8226b3dd8dbb0,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001311_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,619199,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001328,ADIRP0001328_TCRB,DNA,Illumina,5f4c16fa83a8226b3dd8dbb3, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,41,41,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute,Orencia, , ,"Autoimmune hepatitis, Rheumatoid arthritis, Heart PVC and PAC, Stroke",5f4c16fa83a8226b3dd8dbb3,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,41 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,619199,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16fa83a8226b3dd8dbb3,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001328_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,898043,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001349,ADIRP0001349_TCRB,DNA,Illumina,5f4c16fb83a8226b3dd8dbb4, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,30,30,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,15 d,Recovered, , , , ,5f4c16fb83a8226b3dd8dbb4,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,80 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,898043,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16fb83a8226b3dd8dbb4,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001349_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,822007,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001353,ADIRP0001353_TCRB,DNA,Illumina,5f4c16fc83a8226b3dd8dbb5, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,51,51,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,2 d,Recovered, , , , ,5f4c16fc83a8226b3dd8dbb5,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,15 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,822007,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16fc83a8226b3dd8dbb5,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001353_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,862820,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001388,ADIRP0001388_TCRB,DNA,Illumina,5f4c16fd83a8226b3dd8dbb6, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,28,28,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,11 d,Recovered,Fluticasone propionate 50 mcg spray. One spray each nostril once/day., , , ,5f4c16fd83a8226b3dd8dbb6,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,27 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,862820,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16fd83a8226b3dd8dbb6,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001388_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,744780,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001427,ADIRP0001427_TCRB,DNA,Illumina,5f4c16fe83a8226b3dd8dbb7, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,37,37,year,UO:0000036,Sample Collection, , ,German/East Indian, , , ,DOID:0080600, ,Acute, , , , ,5f4c16fe83a8226b3dd8dbb7,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,13 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,744780,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16fe83a8226b3dd8dbb7,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001427_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1183151,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001463,ADIRP0001463_TCRB,DNA,Illumina,5f4c16fe83a8226b3dd8dbb8, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,40,40,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , ,Graves disease,5f4c16fe83a8226b3dd8dbb8,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,30 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1183151,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16fe83a8226b3dd8dbb8,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001463_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,758319,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001479,ADIRP0001479_TCRB,DNA,Illumina,5f4c16ff83a8226b3dd8dbb9, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,64,64,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered,Levothyroxine, , ,"Graves disease - radiated thyroid -  developed hypothyroidism, Hypertension",5f4c16ff83a8226b3dd8dbb9,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,37 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,758319,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c16ff83a8226b3dd8dbb9,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001479_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,544555,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001510,ADIRP0001510_TCRB,DNA,Illumina,5f4c170083a8226b3dd8dbba, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,52,52,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,13 d,Recovered, , , ,Breast cancer,5f4c170083a8226b3dd8dbba,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,92 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,544555,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170083a8226b3dd8dbba,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001510_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,736768,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001555,ADIRP0001555_TCRB,DNA,Illumina,5f4c170183a8226b3dd8dbbb, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,61,61,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , ,"Skin cancer (eyelid and arms), Osteio arthritis, Fybromayalgia, Asthma",5f4c170183a8226b3dd8dbbb,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,91 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,736768,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170183a8226b3dd8dbbb,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001555_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,616652,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001657,ADIRP0001657_TCRB,DNA,Illumina,5f4c170283a8226b3dd8dbbc, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,44,44,year,UO:0000036,Sample Collection, , ,Mixed racial group, , , ,DOID:0080600, ,Acute, , , , ,5f4c170283a8226b3dd8dbbc,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,62 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,616652,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170283a8226b3dd8dbbc,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001657_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,825937,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001674,ADIRP0001674_TCRB,DNA,Illumina,5f4c170383a8226b3dd8dbbd, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,45,45,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f4c170383a8226b3dd8dbbd,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,14 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,825937,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170383a8226b3dd8dbbd,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001674_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,685476,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001717,ADIRP0001717_TCRB,DNA,Illumina,5f4c170383a8226b3dd8dbbe, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,55,55,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,35 d,Recovered, , , ,Hypertension,5f4c170383a8226b3dd8dbbe,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,45 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,685476,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170383a8226b3dd8dbbe,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001717_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,681860,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001726,ADIRP0001726_TCRB,DNA,Illumina,5f4c170483a8226b3dd8dbbf, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,56,56,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , ,"Neuropathy, Diabetes (Type 2), Hypertension",5f4c170483a8226b3dd8dbbf,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,67 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,681860,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170483a8226b3dd8dbbf,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001726_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,663474,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001764,ADIRP0001764_TCRB,DNA,Illumina,5f4c170583a8226b3dd8dbc0, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,64,64,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f4c170583a8226b3dd8dbc0,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,88 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,663474,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170583a8226b3dd8dbc0,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001764_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,774771,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001786,ADIRP0001786_TCRB,DNA,Illumina,5f4c170683a8226b3dd8dbc1, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,33,33,year,UO:0000036,Sample Collection, , ,Hispanic, , , ,DOID:0080600, ,Acute, , , ,Hypertension ,5f4c170683a8226b3dd8dbc1,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,9 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,774771,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170683a8226b3dd8dbc1,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001786_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,978881,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001865,ADIRP0001865_TCRB,DNA,Illumina,5f4c170783a8226b3dd8dbc3, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,38,38,year,UO:0000036,Sample Collection, , ,Asian or Pacific Islander, , , ,DOID:0080600,12 d,Recovered,Levothyroxine 112mcg, , ,Hashimoto's thyroiditis,5f4c170783a8226b3dd8dbc3,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,63 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,978881,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170783a8226b3dd8dbc3,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001865_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,690891,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001869,ADIRP0001869_TCRB,DNA,Illumina,5f4c170883a8226b3dd8dbc4, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,51,51,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , ,"Hypothyroidism, Reflux, Asthma",5f4c170883a8226b3dd8dbc4,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,96 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,690891,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170883a8226b3dd8dbc4,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001869_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,545714,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001895,ADIRP0001895_TCRB,DNA,Illumina,5f4c170a83a8226b3dd8dbc7, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,37,37,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , , ,5f4c170a83a8226b3dd8dbc7,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,28 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,545714,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170a83a8226b3dd8dbc7,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001895_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,490145,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001903,ADIRP0001903_TCRB,DNA,Illumina,5f4c170b83a8226b3dd8dbc8, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,30,30,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,23 d,Recovered, , , , ,5f4c170b83a8226b3dd8dbc8,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,40 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,490145,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170b83a8226b3dd8dbc8,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001903_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,583403,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001922,ADIRP0001922_TCRB,DNA,Illumina,5f4c170d83a8226b3dd8dbca, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,61,61,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,11 d,Recovered, , , , ,5f4c170d83a8226b3dd8dbca,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,71 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,583403,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170d83a8226b3dd8dbca,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001922_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,817854,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001929,ADIRP0001929_TCRB,DNA,Illumina,5f4c170e83a8226b3dd8dbcb, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,36,36,year,UO:0000036,Sample Collection, , ,Mixed racial group, , , ,DOID:0080600,7 d,Recovered, , , , ,5f4c170e83a8226b3dd8dbcb,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,73 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,817854,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170e83a8226b3dd8dbcb,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001929_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,946048,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001950,ADIRP0001950_TCRB,DNA,Illumina,5f4c170f83a8226b3dd8dbcc, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,54,54,year,UO:0000036,Sample Collection, , ,Hispanic, , , ,DOID:0080600, ,Acute, , , ,"Malignant melanoma, Psoriasis, Asthma, Diabetes (Type 2)",5f4c170f83a8226b3dd8dbcc,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,26 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,946048,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170f83a8226b3dd8dbcc,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001950_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,368510,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0001958,ADIRP0001958_TCRB,DNA,Illumina,5f4c170f83a8226b3dd8dbcd, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,49,49,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f4c170f83a8226b3dd8dbcd,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,16 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,368510,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c170f83a8226b3dd8dbcd,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0001958_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,650594,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002010,ADIRP0002010_TCRB,DNA,Illumina,5f4c171183a8226b3dd8dbcf, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,47,47,year,UO:0000036,Sample Collection, , ,Hispanic, , , ,DOID:0080600, ,Acute, , , ,Hypertension,5f4c171183a8226b3dd8dbcf,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,12 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,650594,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171183a8226b3dd8dbcf,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002010_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,558999,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002034,ADIRP0002034_TCRB,DNA,Illumina,5f4c171283a8226b3dd8dbd0, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,51,51,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,28 d,Recovered, , , ,Hypertension,5f4c171283a8226b3dd8dbd0,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,82 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,558999,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171283a8226b3dd8dbd0,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002034_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,796565,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002065,ADIRP0002065_TCRB,DNA,Illumina,5f4c171483a8226b3dd8dbd2, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,43,43,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , ,Asthma,5f4c171483a8226b3dd8dbd2,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,84 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,796565,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171483a8226b3dd8dbd2,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002065_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,623176,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002082,ADIRP0002082_TCRB,DNA,Illumina,5f4c171483a8226b3dd8dbd3, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,31,31,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,14 d,Recovered, , , , ,5f4c171483a8226b3dd8dbd3,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,76 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,623176,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171483a8226b3dd8dbd3,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002082_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,600316,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002104,ADIRP0002104_TCRB,DNA,Illumina,5f4c171583a8226b3dd8dbd4, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,49,49,year,UO:0000036,Sample Collection, , ,Black or African American, , , ,DOID:0080600,45 d,Recovered, , , ,"Diabetes (Type 2), Hypertension",5f4c171583a8226b3dd8dbd4,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,36 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,600316,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171583a8226b3dd8dbd4,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002104_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,895575,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002156,ADIRP0002156_TCRB,DNA,Illumina,5f4c171683a8226b3dd8dbd5, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,34,34,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,25 d,Recovered, , , , ,5f4c171683a8226b3dd8dbd5,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,59 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,895575,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171683a8226b3dd8dbd5,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002156_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,919434,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002184,ADIRP0002184_TCRB,DNA,Illumina,5f4c171883a8226b3dd8dbd7, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,38,38,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,12 d,Recovered, , , ,Lymes disease,5f4c171883a8226b3dd8dbd7,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,100 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,919434,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171883a8226b3dd8dbd7,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002184_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,412933,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002279,ADIRP0002279_TCRB,DNA,Illumina,5f4c171983a8226b3dd8dbd8, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,22,22,year,UO:0000036,Sample Collection, , ,Mixed racial group, , , ,DOID:0080600,5 d,Recovered, , , , ,5f4c171983a8226b3dd8dbd8,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,51 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,412933,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171983a8226b3dd8dbd8,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002279_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,886401,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002291,ADIRP0002291_TCRB,DNA,Illumina,5f4c171983a8226b3dd8dbd9, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,41,41,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,7 d,Recovered, , , , ,5f4c171983a8226b3dd8dbd9,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,30 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,886401,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171983a8226b3dd8dbd9,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002291_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,540533,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002300,ADIRP0002300_TCRB,DNA,Illumina,5f4c171a83a8226b3dd8dbda, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,35,35,year,UO:0000036,Sample Collection, , ,Asian or Pacific Islander, , , ,DOID:0080600,13 d,Recovered, , , , ,5f4c171a83a8226b3dd8dbda,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,23 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,540533,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171a83a8226b3dd8dbda,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002300_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,865984,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002301,ADIRP0002301_TCRB,DNA,Illumina,5f4c171b83a8226b3dd8dbdb, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,37,37,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,5 d,Recovered, , , , ,5f4c171b83a8226b3dd8dbdb,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,78 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,865984,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171b83a8226b3dd8dbdb,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002301_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,656975,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002340,ADIRP0002340_TCRB,DNA,Illumina,5f4c171c83a8226b3dd8dbdc, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,56,56,year,UO:0000036,Sample Collection, , ,Mixed racial group, , , ,DOID:0080600, ,Recovered, , , , ,5f4c171c83a8226b3dd8dbdc,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,45 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,656975,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171c83a8226b3dd8dbdc,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002340_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,445909,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002343,ADIRP0002343_TCRB,DNA,Illumina,5f4c171c83a8226b3dd8dbdd, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,52,52,year,UO:0000036,Sample Collection, , ,Hispanic, , , ,DOID:0080600,5 d,Acute, , , , ,5f4c171c83a8226b3dd8dbdd,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,21 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,445909,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171c83a8226b3dd8dbdd,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002343_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,383901,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002417,ADIRP0002417_TCRB,DNA,Illumina,5f4c171e83a8226b3dd8dbdf, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,33,33,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Recovered, , , , ,5f4c171e83a8226b3dd8dbdf,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,79 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,383901,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171e83a8226b3dd8dbdf,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002417_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,596112,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002425,ADIRP0002425_TCRB,DNA,Illumina,5f4c171f83a8226b3dd8dbe0, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,62,62,year,UO:0000036,Sample Collection, , ,Black or African American, , , ,DOID:0080600,23 d,Recovered, , , ,"Diabetes (Type 2), Hypertension",5f4c171f83a8226b3dd8dbe0,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,88 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,596112,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171f83a8226b3dd8dbe0,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002425_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,160200,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002427,ADIRP0002427_TCRB,DNA,Illumina,5f4c171f83a8226b3dd8dbe1, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,51,51,year,UO:0000036,Sample Collection, , ,Hispanic, , , ,DOID:0080600, ,Acute, , , ,"Psoriasis, Rheumatoid arthritis, Hypertension",5f4c171f83a8226b3dd8dbe1,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,36 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,160200,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c171f83a8226b3dd8dbe1,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002427_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,616060,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002436,ADIRP0002436_TCRB,DNA,Illumina,5f4c172183a8226b3dd8dbe3, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,40,40,year,UO:0000036,Sample Collection, , ,Hispanic, , , ,DOID:0080600, ,Acute, , , , ,5f4c172183a8226b3dd8dbe3,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,10 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,616060,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c172183a8226b3dd8dbe3,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002436_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,189884,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002464,ADIRP0002464_TCRB,DNA,Illumina,5f4c172383a8226b3dd8dbe5, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,46,46,year,UO:0000036,Sample Collection, , ,Hispanic, , , ,DOID:0080600, ,Acute, , , , ,5f4c172383a8226b3dd8dbe5,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,17 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,189884,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c172383a8226b3dd8dbe5,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002464_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,744908,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002474,ADIRP0002474_TCRB,DNA,Illumina,5f4c172483a8226b3dd8dbe6, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,42,42,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,25 d,Recovered, , , ,Asthma,5f4c172483a8226b3dd8dbe6,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,41 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,744908,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c172483a8226b3dd8dbe6,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002474_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,866816,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002497,ADIRP0002497_TCRB,DNA,Illumina,5f4c172483a8226b3dd8dbe7, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,34,34,year,UO:0000036,Sample Collection, , ,Mixed racial group, , , ,DOID:0080600, ,Recovered, , , , ,5f4c172483a8226b3dd8dbe7,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,66 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,866816,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c172483a8226b3dd8dbe7,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002497_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1321701,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002498,ADIRP0002498_TCRB,DNA,Illumina,5f4c172583a8226b3dd8dbe8, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,61,61,year,UO:0000036,Sample Collection, , ,Black or African American, , , ,DOID:0080600, ,Recovered, , , ,Hypertension,5f4c172583a8226b3dd8dbe8,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,24 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1321701,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c172583a8226b3dd8dbe8,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002498_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,821309,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002512,ADIRP0002512_TCRB,DNA,Illumina,5f4c172883a8226b3dd8dbeb, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,57,57,year,UO:0000036,Sample Collection, , ,Hispanic, , , ,DOID:0080600,21 d,Recovered, , , ,Hypertension,5f4c172883a8226b3dd8dbeb,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,72 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,821309,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c172883a8226b3dd8dbeb,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002512_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,738426,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002514,ADIRP0002514_TCRB,DNA,Illumina,5f4c172983a8226b3dd8dbec, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,19,19,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute,Unithroid 100mcg tablet, , ,"Hashimoto's thyroiditis, Asthma",5f4c172983a8226b3dd8dbec,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,18 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,738426,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c172983a8226b3dd8dbec,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002514_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,689624,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002519,ADIRP0002519_TCRB,DNA,Illumina,5f4c172a83a8226b3dd8dbed, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,27,27,year,UO:0000036,Sample Collection, , ,Asian or Pacific Islander, , , ,DOID:0080600,14 d,Recovered, , , , ,5f4c172a83a8226b3dd8dbed,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,79 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,689624,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c172a83a8226b3dd8dbed,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002519_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,665271,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002520,ADIRP0002520_TCRB,DNA,Illumina,5f4c172a83a8226b3dd8dbee, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,34,34,year,UO:0000036,Sample Collection, , ,Hispanic, , , ,DOID:0080600, ,Acute, , , ,Malignant Phyllodes Tumor,5f4c172a83a8226b3dd8dbee,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,19 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,665271,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c172a83a8226b3dd8dbee,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002520_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,365274,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002562,ADIRP0002562_TCRB,DNA,Illumina,5f4c172b83a8226b3dd8dbef, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,47,47,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute,Stelera - Emgality, , ,Crohn's disease,5f4c172b83a8226b3dd8dbef,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,17 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,365274,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c172b83a8226b3dd8dbef,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002562_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,548628,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0002581,ADIRP0002581_TCRB,DNA,Illumina,5f4c172d83a8226b3dd8dbf1, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,46,46,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f4c172d83a8226b3dd8dbf1,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,24 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,548628,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c172d83a8226b3dd8dbf1,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADIRP0002581_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,441836,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000096,ADRIP00000961_TCRB,DNA,Illumina,5f4c173083a8226b3dd8dbf5, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,51,51,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,3 d,Recovered, , , ,Thyroid cancer,5f4c173083a8226b3dd8dbf5,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,51 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,441836,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c173083a8226b3dd8dbf5,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADRIP00000961_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-Adaptive: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1045395,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-Adaptive,ADIRP0000160,ADRIP0000160_TCRB,DNA,Illumina,5f4c173183a8226b3dd8dbf6, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,29,29,year,UO:0000036,Sample Collection, , ,Caucasian, , , ,DOID:0080600,9 d,Recovered, , , , ,5f4c173183a8226b3dd8dbf6,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,57 d,Diagnosis,"Adaptive Biotechnologies/Microsoft - immuneRACE and Antigen Map COVID19: immune response to COVID-19 (with Microsoft); cDNA or gDNA from T cells, B-cell depleted T cells, or PBMCs", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1045395,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f4c173183a8226b3dd8dbf6,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""ADRIP0000160_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,575917,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,1,INCOV001-AC-5_TCRB,DNA,Illumina,5f491afd6d45ecc67f6d3410, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,77,77,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Remdesivir (RDV), Lisinopril (Prinivil)", , ,Chronic hypertension,5f491afd6d45ecc67f6d3410,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,12 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,575917,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491afd6d45ecc67f6d3410,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV001-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,383972,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,2,INCOV002-AC-5_TCRB,DNA,Illumina,5f491afe6d45ecc67f6d3411, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,39,39,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Hydroxychloroquine (HCQ), Remdesivir (RDV), Tocilizumab, Tocilizumab, Tocilizumab, Vitamin C, Zinc", ,Mechanical ventilation, ,5f491afe6d45ecc67f6d3411,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,7 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,383972,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491afe6d45ecc67f6d3411,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV002-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,519374,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,2,INCOV002-BL-5_TCRB,DNA,Illumina,5f491afe6d45ecc67f6d3412, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,39,39,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Hydroxychloroquine (HCQ), Remdesivir (RDV), Tocilizumab, Tocilizumab, Tocilizumab, Vitamin C, Zinc", , , ,5f491afe6d45ecc67f6d3412,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,2 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,519374,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491afe6d45ecc67f6d3412,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV002-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1087648,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,2,INCOV002-CV-3_TCRB,DNA,Illumina,5f491aff6d45ecc67f6d3413, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,39,39,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Convalescent,"Hydroxychloroquine (HCQ), Remdesivir (RDV), Tocilizumab, Tocilizumab, Tocilizumab, Vitamin C, Zinc", , , ,5f491aff6d45ecc67f6d3413,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1087648,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491aff6d45ecc67f6d3413,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV002-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,495464,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,3,INCOV003-AC-5_TCRB,DNA,Illumina,5f491b006d45ecc67f6d3414, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,64,64,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Tocilizumab, Tocilizumab, Vitamin C, Hydroxychloroquine (HCQ), Remdesivir (RDV), Lisinopril (Prinivil)", ,Mechanical ventilation,"Chronic hypertension, Chronic kidney disease",5f491b006d45ecc67f6d3414,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,14 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,495464,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b006d45ecc67f6d3414,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV003-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,103914,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,3,INCOV003-BL-5_TCRB,DNA,Illumina,5f491b016d45ecc67f6d3415, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,64,64,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Tocilizumab, Tocilizumab, Vitamin C, Hydroxychloroquine (HCQ), Remdesivir (RDV), Lisinopril (Prinivil)", ,Mechanical ventilation,"Chronic hypertension, Chronic kidney disease",5f491b016d45ecc67f6d3415,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,8 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,103914,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b016d45ecc67f6d3415,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV003-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,239880,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,4,INCOV004-AC-5_TCRB,DNA,Illumina,5f491b026d45ecc67f6d3416, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,76,76,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Remdesivir (RDV), Losartan (Cozaar)", ,Nasal cannula,"Chronic lymphocytic leukemia, Congestive heart failure, Chronic obstructive pulmonary disease, Coronary artery disease, Immunocompromised",5f491b026d45ecc67f6d3416,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,6 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,239880,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b026d45ecc67f6d3416,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV004-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,119782,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,4,INCOV004-BL-5_TCRB,DNA,Illumina,5f491b026d45ecc67f6d3417, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,76,76,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Remdesivir (RDV), Losartan (Cozaar)", ,Nasal cannula,"Chronic lymphocytic leukemia, Congestive heart failure, Chronic obstructive pulmonary disease, Coronary artery disease, Immunocompromised",5f491b026d45ecc67f6d3417,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,1 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,119782,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b026d45ecc67f6d3417,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV004-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,241912,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,5,INCOV005-AC-5_TCRB,DNA,Illumina,5f491b036d45ecc67f6d3418, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,75,75,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Tocilizumab, Tocilizumab, Tocilizumab, Vitamin C, Steroid, Remdesivir (RDV), HCQ + Azithromycin", , ,"Chronic hypertension, Chronic obstructive pulmonary disease",5f491b036d45ecc67f6d3418,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,5 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,241912,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b036d45ecc67f6d3418,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV005-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,97951,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,5,INCOV005-BL-5_TCRB,DNA,Illumina,5f491b046d45ecc67f6d3419, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,75,75,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Tocilizumab, Tocilizumab, Tocilizumab, Vitamin C, Steroid, Remdesivir (RDV), HCQ + Azithromycin", ,Nasal cannula,"Chronic hypertension, Chronic obstructive pulmonary disease",5f491b046d45ecc67f6d3419,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,1 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,97951,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b046d45ecc67f6d3419,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV005-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,405882,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,5,INCOV005-CV-3_TCRB,DNA,Illumina,5f491b056d45ecc67f6d341a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,75,75,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Convalescent,"Tocilizumab, Tocilizumab, Tocilizumab, Vitamin C, Steroid, Remdesivir (RDV), HCQ + Azithromycin", , ,"Chronic hypertension, Chronic obstructive pulmonary disease",5f491b056d45ecc67f6d341a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,61 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,405882,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b056d45ecc67f6d341a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV005-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,386486,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,6,INCOV006-AC-5_TCRB,DNA,Illumina,5f491b066d45ecc67f6d341b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,26,26,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Acute,"Remdesivir (RDV), Tocilizumab, Vitamin C", , , ,5f491b066d45ecc67f6d341b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,6 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,386486,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b066d45ecc67f6d341b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV006-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,218845,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,6,INCOV006-BL-5_TCRB,DNA,Illumina,5f491b076d45ecc67f6d341c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,26,26,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Baseline,"Remdesivir (RDV), Tocilizumab, Vitamin C", ,Nasal cannula, ,5f491b076d45ecc67f6d341c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,2 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,218845,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b076d45ecc67f6d341c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV006-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,497686,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,6,INCOV006-CV-3_TCRB,DNA,Illumina,5f491b076d45ecc67f6d341d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,26,26,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Convalescent,"Remdesivir (RDV), Tocilizumab, Vitamin C", , , ,5f491b076d45ecc67f6d341d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,497686,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b076d45ecc67f6d341d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV006-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,244227,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,7,INCOV007-AC-5_TCRB,DNA,Illumina,5f491b086d45ecc67f6d341e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,57,57,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Remdesivir (RDV), Hydrochlorothiazide/lisinopril (Zestoretic)", ,Nasal cannula,Chronic hypertension,5f491b086d45ecc67f6d341e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,4 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,244227,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b086d45ecc67f6d341e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV007-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,223791,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,7,INCOV007-BL-5_TCRB,DNA,Illumina,5f491b096d45ecc67f6d341f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,57,57,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Remdesivir (RDV), Hydrochlorothiazide/lisinopril (Zestoretic)", ,Nasal cannula,Chronic hypertension,5f491b096d45ecc67f6d341f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,0 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,223791,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b096d45ecc67f6d341f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV007-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,736000,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,7,INCOV007-CV-3_TCRB,DNA,Illumina,5f491b0a6d45ecc67f6d3420, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,57,57,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Convalescent,"Remdesivir (RDV), Hydrochlorothiazide/lisinopril (Zestoretic)", , ,Chronic hypertension,5f491b0a6d45ecc67f6d3420,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,736000,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b0a6d45ecc67f6d3420,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV007-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,106333,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,8,INCOV008-BL-5_TCRB,DNA,Illumina,5f491b0b6d45ecc67f6d3421, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,78,78,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Black or African American, , , ,DOID:0080600, ,Baseline,"HCQ + Azithromycin, Tocilizumab, Tocilizumab, Tocilizumab, Vitamin C, Zinc", ,Mechanical ventilation,Multiple myeloma,5f491b0b6d45ecc67f6d3421,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,0 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,106333,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b0b6d45ecc67f6d3421,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV008-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,161495,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,9,INCOV009-BL-5_TCRB,DNA,Illumina,5f491b0b6d45ecc67f6d3422, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,65,65,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Baseline,"Remdesivir (RDV), Losartan (Cozaar)", ,Nasal cannula,"Diabetes (Type 2), Chronic kidney disease, Coronary artery disease",5f491b0b6d45ecc67f6d3422,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,13 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,161495,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b0b6d45ecc67f6d3422,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV009-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,309935,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,11,INCOV011-AC-5_TCRB,DNA,Illumina,5f491b0c6d45ecc67f6d3423, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,89,89,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Hydroxychloroquine (HCQ), Hydroxychloroquine (HCQ), Losartan (Cozaar)", , ,"Chronic hypertension, Coronary artery disease",5f491b0c6d45ecc67f6d3423,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,3 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,309935,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b0c6d45ecc67f6d3423,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV011-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,758903,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,12,INCOV012-AC-5_TCRB,DNA,Illumina,5f491b0d6d45ecc67f6d3424, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,73,73,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Remdesivir (RDV), Acetaminophen, Lisinopril (Prinivil)", ,Nasal cannula,"Diabetes (Type 2), Chronic hypertension, Congestive heart failure, Coronary artery disease",5f491b0d6d45ecc67f6d3424,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,5 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,758903,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b0d6d45ecc67f6d3424,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV012-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,623608,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,12,INCOV012-CV-3_TCRB,DNA,Illumina,5f491b0e6d45ecc67f6d3425, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,73,73,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Convalescent,"Remdesivir (RDV), Acetaminophen, Lisinopril (Prinivil)", , ,"Diabetes (Type 2), Chronic hypertension, Congestive heart failure, Coronary artery disease",5f491b0e6d45ecc67f6d3425,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,623608,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b0e6d45ecc67f6d3425,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV012-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,65900,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,13,INCOV013-AC-5_TCRB,DNA,Illumina,5f491b0f6d45ecc67f6d3426, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,71,71,year,UO:0000036,Sample Collection, ,Unknown Ethnicity,Caucasian, , , ,DOID:0080600, ,Acute,"Tocilizumab, Vitamin C, Zinc, Other, Hydroxychloroquine (HCQ), Remdesivir (RDV), Lisinopril (Prinivil)", , ,Chronic hypertension,5f491b0f6d45ecc67f6d3426,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,8 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,65900,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b0f6d45ecc67f6d3426,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV013-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,263917,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,13,INCOV013-CV-3_TCRB,DNA,Illumina,5f491b0f6d45ecc67f6d3427, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,71,71,year,UO:0000036,Sample Collection, ,Unknown Ethnicity,Caucasian, , , ,DOID:0080600, ,Convalescent,"Tocilizumab, Vitamin C, Zinc, Other, Hydroxychloroquine (HCQ), Remdesivir (RDV), Lisinopril (Prinivil)", , ,Chronic hypertension,5f491b0f6d45ecc67f6d3427,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,57 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,263917,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b0f6d45ecc67f6d3427,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV013-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,419879,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,14,INCOV014-BL-5_TCRB,DNA,Illumina,5f491b106d45ecc67f6d3428, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,76,76,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Remdesivir (RDV), Tocilizumab", ,Nasal cannula, ,5f491b106d45ecc67f6d3428,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,3 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,419879,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b106d45ecc67f6d3428,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV014-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,479613,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,15,INCOV015-AC-5_TCRB,DNA,Illumina,5f491b116d45ecc67f6d3429, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,67,67,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Acute,"Remdesivir (RDV), Tocilizumab, Tocilizumab, Acetaminophen, Hydrochlorothiazide/valsartan (Diovan HCT)", , ,Chronic hypertension,5f491b116d45ecc67f6d3429,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,7 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,479613,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b116d45ecc67f6d3429,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV015-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,176707,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,15,INCOV015-BL-5_TCRB,DNA,Illumina,5f491b126d45ecc67f6d342a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,67,67,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Baseline,"Remdesivir (RDV), Tocilizumab, Tocilizumab, Acetaminophen, Hydrochlorothiazide/valsartan (Diovan HCT)", ,Nasal cannula,Chronic hypertension,5f491b126d45ecc67f6d342a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,3 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,176707,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b126d45ecc67f6d342a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV015-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,248899,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,16,INCOV016-AC-5_TCRB,DNA,Illumina,5f491b136d45ecc67f6d342b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,37,37,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Acute,"Tocilizumab, Remdesivir (RDV)", ,Nasal cannula, ,5f491b136d45ecc67f6d342b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,3 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,248899,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b136d45ecc67f6d342b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV016-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,242433,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,16,INCOV016-BL-5_TCRB,DNA,Illumina,5f491b146d45ecc67f6d342c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,37,37,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Baseline,"Tocilizumab, Remdesivir (RDV)", ,Nasal cannula, ,5f491b146d45ecc67f6d342c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,1 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,242433,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b146d45ecc67f6d342c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV016-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,580976,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,16,INCOV016-CV-3_TCRB,DNA,Illumina,5f491b156d45ecc67f6d342d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,37,37,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Convalescent,"Tocilizumab, Remdesivir (RDV)", , , ,5f491b156d45ecc67f6d342d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,580976,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b156d45ecc67f6d342d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV016-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,267567,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,17,INCOV017-AC-5_TCRB,DNA,Illumina,5f491b166d45ecc67f6d342e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,57,57,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Acute,Remdesivir (RDV), , ,Chronic hypertension,5f491b166d45ecc67f6d342e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,13 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,267567,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b166d45ecc67f6d342e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV017-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,211797,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,17,INCOV017-BL-5_TCRB,DNA,Illumina,5f491b176d45ecc67f6d342f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,57,57,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Baseline,Remdesivir (RDV), , ,Chronic hypertension,5f491b176d45ecc67f6d342f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,11 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,211797,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b176d45ecc67f6d342f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV017-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,350430,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,17,INCOV017-CV-3_TCRB,DNA,Illumina,5f491b196d45ecc67f6d3430, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,57,57,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Convalescent,Remdesivir (RDV), , ,Chronic hypertension,5f491b196d45ecc67f6d3430,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,350430,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b196d45ecc67f6d3430,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV017-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,51756,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,18,INCOV018-AC-5_TCRB,DNA,Illumina,5f491b196d45ecc67f6d3431, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,69,69,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Hydroxychloroquine (HCQ), HCQ + Azithromycin, Remdesivir (RDV), Tocilizumab, Tocilizumab, Tocilizumab, Zinc, Acetaminophen", , ,"Chronic hypertension, Congestive heart failure",5f491b196d45ecc67f6d3431,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,24 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,51756,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b196d45ecc67f6d3431,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV018-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,49416,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,18,INCOV018-BL-5_TCRB,DNA,Illumina,5f491b1a6d45ecc67f6d3432, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,69,69,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Hydroxychloroquine (HCQ), HCQ + Azithromycin, Remdesivir (RDV), Tocilizumab, Tocilizumab, Tocilizumab, Zinc, Acetaminophen", ,Extracorporeal membrane oxygenation,"Chronic hypertension, Congestive heart failure",5f491b1a6d45ecc67f6d3432,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,22 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,49416,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b1a6d45ecc67f6d3432,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV018-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,74159,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,18,INCOV018-CV-3_TCRB,DNA,Illumina,5f491b1b6d45ecc67f6d3433, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,69,69,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Convalescent,"Hydroxychloroquine (HCQ), HCQ + Azithromycin, Remdesivir (RDV), Tocilizumab, Tocilizumab, Tocilizumab, Zinc, Acetaminophen", , ,"Chronic hypertension, Congestive heart failure",5f491b1b6d45ecc67f6d3433,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,71 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,74159,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b1b6d45ecc67f6d3433,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV018-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,484521,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,19,INCOV019-AC-5_TCRB,DNA,Illumina,5f491b1c6d45ecc67f6d3434, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,81,81,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Hydroxychloroquine (HCQ), Lisinopril (Prinivil)", , ,"Diabetes (Type 2), Chronic hypertension",5f491b1c6d45ecc67f6d3434,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,11 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,484521,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b1c6d45ecc67f6d3434,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV019-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,403626,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,19,INCOV019-BL-5_TCRB,DNA,Illumina,5f491b1d6d45ecc67f6d3435, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,81,81,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Hydroxychloroquine (HCQ), Lisinopril (Prinivil)", , ,"Diabetes (Type 2), Chronic hypertension",5f491b1d6d45ecc67f6d3435,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,6 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,403626,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b1d6d45ecc67f6d3435,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV019-BL-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,98276,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,20,INCOV020-AC-5_TCRB,DNA,Illumina,5f491b1e6d45ecc67f6d3436, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,55,55,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Acute,"Hydroxychloroquine (HCQ), Other, Plasma Transfusions, Zinc", ,Mechanical ventilation,Diabetes (Type 2),5f491b1e6d45ecc67f6d3436,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,7 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,98276,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b1e6d45ecc67f6d3436,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV020-AC-5_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,229613,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,22,INCOV022-AC-3_TCRB,DNA,Illumina,5f491b1f6d45ecc67f6d3437, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,55,55,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Black or African American, , , ,DOID:0080600, ,Acute,"Plasma Transfusions, Vitamin C, Zinc, Lisinopril (Prinivil)", ,Mechanical ventilation,"Diabetes (Type 2), Chronic hypertension",5f491b1f6d45ecc67f6d3437,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,9 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,229613,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b1f6d45ecc67f6d3437,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV022-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,916318,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,22,INCOV022-CV-3_TCRB,DNA,Illumina,5f491b1f6d45ecc67f6d3438, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,55,55,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Black or African American, , , ,DOID:0080600, ,Convalescent,"Plasma Transfusions, Vitamin C, Zinc, Lisinopril (Prinivil)", , ,"Diabetes (Type 2), Chronic hypertension",5f491b1f6d45ecc67f6d3438,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,916318,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b1f6d45ecc67f6d3438,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV022-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,968183,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,23,INCOV023-AC-3_TCRB,DNA,Illumina,5f491b206d45ecc67f6d3439, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,71,71,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Black or African American, , , ,DOID:0080600, ,Acute,Remdesivir (RDV), , ,Chronic hypertension,5f491b206d45ecc67f6d3439,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,8 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,968183,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b206d45ecc67f6d3439,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV023-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,926157,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,23,INCOV023-CV-3_TCRB,DNA,Illumina,5f491b216d45ecc67f6d343a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,71,71,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Black or African American, , , ,DOID:0080600, ,Convalescent,Remdesivir (RDV), , ,Chronic hypertension,5f491b216d45ecc67f6d343a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,926157,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b216d45ecc67f6d343a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV023-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,317694,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,24,INCOV024-AC-3_TCRB,DNA,Illumina,5f491b226d45ecc67f6d343b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,61,61,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Hydroxychloroquine (HCQ), Plasma Transfusions", , ,"Asthma, Chronic hypertension",5f491b226d45ecc67f6d343b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,14 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,317694,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b226d45ecc67f6d343b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV024-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,418233,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,24,INCOV024-CV-3_TCRB,DNA,Illumina,5f491b236d45ecc67f6d343c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,61,61,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Convalescent,"Hydroxychloroquine (HCQ), Plasma Transfusions", , ,"Asthma, Chronic hypertension",5f491b236d45ecc67f6d343c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,418233,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b236d45ecc67f6d343c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV024-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,366225,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,25,INCOV025-AC-3_TCRB,DNA,Illumina,5f491b236d45ecc67f6d343d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,67,67,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Tocilizumab, Tocilizumab, Tocilizumab", , , ,5f491b236d45ecc67f6d343d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,2 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,366225,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b236d45ecc67f6d343d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV025-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,507301,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,26,INCOV026-AC-3_TCRB,DNA,Illumina,5f491b246d45ecc67f6d343e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,33,33,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Acute,"Tocilizumab, Tocilizumab, Tocilizumab, Vitamin C, Remdesivir (RDV), Hydroxychloroquine (HCQ)", ,"Extracorporeal membrane oxygenation, Mechanical ventilation", ,5f491b246d45ecc67f6d343e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,16 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,507301,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b246d45ecc67f6d343e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV026-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,411373,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,26,INCOV026-BL-3_TCRB,DNA,Illumina,5f491b256d45ecc67f6d343f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,33,33,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Baseline,"Tocilizumab, Tocilizumab, Tocilizumab, Vitamin C, Remdesivir (RDV), Hydroxychloroquine (HCQ)", ,"Extracorporeal membrane oxygenation, Mechanical ventilation", ,5f491b256d45ecc67f6d343f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,14 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,411373,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b256d45ecc67f6d343f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV026-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,741968,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,27,INCOV027-AC-3_TCRB,DNA,Illumina,5f491b266d45ecc67f6d3440, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,38,38,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Acute,Remdesivir (RDV), ,Nasal cannula,"Diabetes (Type 2),  Asthma",5f491b266d45ecc67f6d3440,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,12 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,741968,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b266d45ecc67f6d3440,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV027-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,765181,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,27,INCOV027-BL-3_TCRB,DNA,Illumina,5f491b276d45ecc67f6d3441, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,38,38,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Baseline,Remdesivir (RDV), , ,"Diabetes (Type 2),  Asthma",5f491b276d45ecc67f6d3441,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,7 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,765181,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b276d45ecc67f6d3441,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV027-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1139709,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,27,INCOV027-CV-3_TCRB,DNA,Illumina,5f491b276d45ecc67f6d3442, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,38,38,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Convalescent,Remdesivir (RDV), , ,"Diabetes (Type 2),  Asthma",5f491b276d45ecc67f6d3442,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1139709,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b276d45ecc67f6d3442,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV027-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,85228,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,28,INCOV028-AC-3_TCRB,DNA,Illumina,5f491b286d45ecc67f6d3443, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,64,64,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Acute,"Plasma Transfusions, Acetaminophen, Losartan (Cozaar)", , ,"Diabetes (Type 1), Chronic hypertension, Chronic kidney disease, Coronary artery disease",5f491b286d45ecc67f6d3443,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,20 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,85228,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b286d45ecc67f6d3443,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV028-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,97482,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,28,INCOV028-BL-3_TCRB,DNA,Illumina,5f491b296d45ecc67f6d3444, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,64,64,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Baseline,"Plasma Transfusions, Acetaminophen, Losartan (Cozaar)", , ,"Diabetes (Type 1), Chronic hypertension, Chronic kidney disease, Coronary artery disease",5f491b296d45ecc67f6d3444,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,16 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,97482,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b296d45ecc67f6d3444,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV028-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,432320,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,29,INCOV029-AC-3_TCRB,DNA,Illumina,5f491b2a6d45ecc67f6d3445, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,66,66,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Black or African American, , , ,DOID:0080600, ,Acute,HCQ + Azithromycin, ,Nasal cannula,"Chronic kidney disease, Chronic obstructive pulmonary disease",5f491b2a6d45ecc67f6d3445,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,12 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,432320,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b2a6d45ecc67f6d3445,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV029-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,477217,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,29,INCOV029-BL-3_TCRB,DNA,Illumina,5f491b2b6d45ecc67f6d3446, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,66,66,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Black or African American, , , ,DOID:0080600, ,Baseline,HCQ + Azithromycin, , ,"Chronic kidney disease, Chronic obstructive pulmonary disease",5f491b2b6d45ecc67f6d3446,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,8 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,477217,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b2b6d45ecc67f6d3446,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV029-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,129968,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,30,INCOV030-AC-3_TCRB,DNA,Illumina,5f491b2b6d45ecc67f6d3447, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,86,86,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,Remdesivir (RDV), , , ,5f491b2b6d45ecc67f6d3447,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,7 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,129968,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b2b6d45ecc67f6d3447,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV030-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,124006,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,30,INCOV030-BL-3_TCRB,DNA,Illumina,5f491b2c6d45ecc67f6d3448, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,86,86,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,Remdesivir (RDV), ,Nasal cannula, ,5f491b2c6d45ecc67f6d3448,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,4 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,124006,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b2c6d45ecc67f6d3448,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV030-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,139998,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,31,INCOV031-AC-3_TCRB,DNA,Illumina,5f491b2d6d45ecc67f6d3449, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,47,47,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Acute,"Plasma Transfusions, Tocilizumab, Tocilizumab, Tocilizumab, Vitamin C, Losartan (Cozaar)", ,Mechanical ventilation,Chronic hypertension,5f491b2d6d45ecc67f6d3449,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,8 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,139998,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b2d6d45ecc67f6d3449,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV031-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,111115,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,31,INCOV031-BL-3_TCRB,DNA,Illumina,5f491b2e6d45ecc67f6d344a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,47,47,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Baseline,"Plasma Transfusions, Tocilizumab, Tocilizumab, Tocilizumab, Vitamin C, Losartan (Cozaar)", ,Mechanical ventilation,Chronic hypertension,5f491b2e6d45ecc67f6d344a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,5 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,111115,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b2e6d45ecc67f6d344a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV031-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,255912,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,32,INCOV032-AC-3_TCRB,DNA,Illumina,5f491b2e6d45ecc67f6d344b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,63,63,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Acute,"Hydroxychloroquine (HCQ), Plasma Transfusions, Acetaminophen", , ,"Diabetes (Type 2), Chronic hypertension, Immunocompromised",5f491b2e6d45ecc67f6d344b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,10 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,255912,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b2e6d45ecc67f6d344b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV032-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,226949,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,32,INCOV032-BL-3_TCRB,DNA,Illumina,5f491b2f6d45ecc67f6d344c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,63,63,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Baseline,"Hydroxychloroquine (HCQ), Plasma Transfusions, Acetaminophen", , ,"Diabetes (Type 2), Chronic hypertension, Immunocompromised",5f491b2f6d45ecc67f6d344c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,7 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,226949,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b2f6d45ecc67f6d344c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV032-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,100755,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,33,INCOV033-AC-3_TCRB,DNA,Illumina,5f491b306d45ecc67f6d344d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,88,88,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Remdesivir (RDV), Acetaminophen", , ,"Uterine cancer s/p hysterectomy & bilateral salpingo-oophrectomy, Chronic hypertension",5f491b306d45ecc67f6d344d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,5 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,100755,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b306d45ecc67f6d344d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV033-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,392367,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,33,INCOV033-BL-3_TCRB,DNA,Illumina,5f491b316d45ecc67f6d344e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,88,88,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Remdesivir (RDV), Acetaminophen", , ,"Uterine cancer s/p hysterectomy & bilateral salpingo-oophrectomy, Chronic hypertension",5f491b316d45ecc67f6d344e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,2 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,392367,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b316d45ecc67f6d344e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV033-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,549995,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,34,INCOV034-AC-3_TCRB,DNA,Illumina,5f491b326d45ecc67f6d344f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,30,30,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Acute,Remdesivir (RDV), , , ,5f491b326d45ecc67f6d344f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,11 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,549995,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b326d45ecc67f6d344f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV034-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,271556,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,34,INCOV034-BL-3_TCRB,DNA,Illumina,5f491b326d45ecc67f6d3450, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,30,30,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Baseline,Remdesivir (RDV), , , ,5f491b326d45ecc67f6d3450,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,2 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,271556,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b326d45ecc67f6d3450,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV034-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,250136,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,35,INCOV035-AC-3_TCRB,DNA,Illumina,5f491b336d45ecc67f6d3451, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,61,61,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Acute,"Tocilizumab, Tocilizumab, Plasma Transfusions", ,Mechanical ventilation,"Diabetes (Type 2), Chronic hypertension",5f491b336d45ecc67f6d3451,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,23 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,250136,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b336d45ecc67f6d3451,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV035-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,329234,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,35,INCOV035-BL-3_TCRB,DNA,Illumina,5f491b346d45ecc67f6d3452, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,61,61,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Baseline,"Tocilizumab, Tocilizumab, Plasma Transfusions", ,Mechanical ventilation,"Diabetes (Type 2), Chronic hypertension",5f491b346d45ecc67f6d3452,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,21 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,329234,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b346d45ecc67f6d3452,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV035-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,92530,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,36,INCOV036-AC-3_TCRB,DNA,Illumina,5f491b356d45ecc67f6d3453, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,51,51,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Plasma Transfusions, Tocilizumab", ,Mechanical ventilation,Asthma,5f491b356d45ecc67f6d3453,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,9 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,92530,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b356d45ecc67f6d3453,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV036-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,152051,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,36,INCOV036-BL-3_TCRB,DNA,Illumina,5f491b366d45ecc67f6d3454, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,51,51,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Plasma Transfusions, Tocilizumab", ,Mechanical ventilation,Asthma,5f491b366d45ecc67f6d3454,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,6 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,152051,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b366d45ecc67f6d3454,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV036-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,571185,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,37,INCOV037-BL-3_TCRB,DNA,Illumina,5f491b376d45ecc67f6d3455, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,70,70,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Black or African American, , , ,DOID:0080600, ,Baseline,"Remdesivir (RDV), Aspirin", , ,"Chronic hypertension, Chronic obstructive pulmonary disease",5f491b376d45ecc67f6d3455,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,571185,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b376d45ecc67f6d3455,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV037-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,615785,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,38,INCOV038-BL-3_TCRB,DNA,Illumina,5f491b376d45ecc67f6d3456, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , , , ,18,18,year,UO:0000036,Sample Collection, , , , , , ,DOID:0080600, ,Baseline,Remdesivir (RDV), , ,Asthma,5f491b376d45ecc67f6d3456,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,615785,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b376d45ecc67f6d3456,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV038-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,674352,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,39,INCOV039-AC-3_TCRB,DNA,Illumina,5f491b386d45ecc67f6d3457, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,38,38,year,UO:0000036,Sample Collection, , , , , , ,DOID:0080600, ,Acute, , , ,Brain Tumor,5f491b386d45ecc67f6d3457,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,674352,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b386d45ecc67f6d3457,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV039-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,781859,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,39,INCOV039-BL-3_TCRB,DNA,Illumina,5f491b396d45ecc67f6d3458, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,38,38,year,UO:0000036,Sample Collection, , , , , , ,DOID:0080600, ,Baseline, , , ,Brain Tumor,5f491b396d45ecc67f6d3458,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,781859,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b396d45ecc67f6d3458,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV039-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,468919,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,40,INCOV040-AC-3_TCRB,DNA,Illumina,5f491b3a6d45ecc67f6d3459, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,76,76,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f491b3a6d45ecc67f6d3459,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,468919,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b3a6d45ecc67f6d3459,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV040-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,493299,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,40,INCOV040-BL-3_TCRB,DNA,Illumina,5f491b3b6d45ecc67f6d345a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,76,76,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , , ,5f491b3b6d45ecc67f6d345a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,493299,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b3b6d45ecc67f6d345a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV040-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,473753,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,41,INCOV041-AC-3_TCRB,DNA,Illumina,5f491b3c6d45ecc67f6d345b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,65,65,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Tocilizumab, Plasma Transfusions, Acetaminophen", ,Mechanical ventilation,"Diabetes (Type 2), Chronic hypertension",5f491b3c6d45ecc67f6d345b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,473753,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b3c6d45ecc67f6d345b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV041-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,93605,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,41,INCOV041-BL-3_TCRB,DNA,Illumina,5f491b3c6d45ecc67f6d345c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,65,65,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Tocilizumab, Plasma Transfusions, Acetaminophen", , ,"Diabetes (Type 2), Chronic hypertension",5f491b3c6d45ecc67f6d345c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,93605,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b3c6d45ecc67f6d345c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV041-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,359952,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,42,INCOV042-AC-3_TCRB,DNA,Illumina,5f491b3d6d45ecc67f6d345d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,60,60,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Acute, , , , ,5f491b3d6d45ecc67f6d345d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,359952,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b3d6d45ecc67f6d345d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV042-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,574611,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,42,INCOV042-BL-3_TCRB,DNA,Illumina,5f491b3e6d45ecc67f6d345e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,60,60,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Baseline, , , , ,5f491b3e6d45ecc67f6d345e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,574611,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b3e6d45ecc67f6d345e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV042-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,291946,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,42,INCOV042-CV-3_TCRB,DNA,Illumina,5f491b3f6d45ecc67f6d345f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,60,60,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Convalescent, , , , ,5f491b3f6d45ecc67f6d345f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,291946,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b3f6d45ecc67f6d345f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV042-CV-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,995188,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,43,INCOV043-AC-3_TCRB,DNA,Illumina,5f491b406d45ecc67f6d3460, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , , , ,75,75,year,UO:0000036,Sample Collection, , , , , , ,DOID:0080600, ,Acute,Acetaminophen, , ,"Diabetes (Type 2), Chronic hypertension",5f491b406d45ecc67f6d3460,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,995188,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b406d45ecc67f6d3460,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV043-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,671215,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,43,INCOV043-BL-3_TCRB,DNA,Illumina,5f491b416d45ecc67f6d3461, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , , , ,75,75,year,UO:0000036,Sample Collection, , , , , , ,DOID:0080600, ,Baseline,Acetaminophen, , ,"Diabetes (Type 2), Chronic hypertension",5f491b416d45ecc67f6d3461,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,671215,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b416d45ecc67f6d3461,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV043-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,322889,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,44,INCOV044-AC-3_TCRB,DNA,Illumina,5f491b426d45ecc67f6d3462, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,82,82,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Remdesivir (RDV), Aspirin", ,Nasal cannula,Chronic hypertension,5f491b426d45ecc67f6d3462,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,6 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,322889,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b426d45ecc67f6d3462,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV044-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,436779,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,44,INCOV044-BL-3_TCRB,DNA,Illumina,5f491b436d45ecc67f6d3463, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,82,82,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Remdesivir (RDV), Aspirin", ,Nasal cannula,Chronic hypertension,5f491b436d45ecc67f6d3463,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,2 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,436779,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b436d45ecc67f6d3463,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV044-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,978171,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,45,INCOV045-AC-3_TCRB,DNA,Illumina,5f491b446d45ecc67f6d3464, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,48,48,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,Acetaminophen, , , ,5f491b446d45ecc67f6d3464,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,978171,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b446d45ecc67f6d3464,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV045-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,675110,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,45,INCOV045-BL-3_TCRB,DNA,Illumina,5f491b456d45ecc67f6d3465, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,48,48,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,Acetaminophen, ,Nasal cannula, ,5f491b456d45ecc67f6d3465,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,11 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,675110,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b456d45ecc67f6d3465,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV045-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,389261,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,47,INCOV047-AC-3_TCRB,DNA,Illumina,5f491b466d45ecc67f6d3466, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,61,61,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,Remdesivir (RDV), , , ,5f491b466d45ecc67f6d3466,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,10 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,389261,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b466d45ecc67f6d3466,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV047-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,356420,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,47,INCOV047-BL-3_TCRB,DNA,Illumina,5f491b466d45ecc67f6d3467, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,61,61,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,Remdesivir (RDV), , , ,5f491b466d45ecc67f6d3467,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,6 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,356420,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b466d45ecc67f6d3467,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV047-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,342118,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,48,INCOV048-BL-3_TCRB,DNA,Illumina,5f491b476d45ecc67f6d3468, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,64,64,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Remdesivir (RDV), Acetaminophen", ,Mechanical ventilation, ,5f491b476d45ecc67f6d3468,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,13 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,342118,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b476d45ecc67f6d3468,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV048-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,193698,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,49,INCOV049-AC-3_TCRB,DNA,Illumina,5f491b486d45ecc67f6d3469, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,82,82,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,Remdesivir (RDV), , ,"Chronic hypertension, Chronic kidney disease, Coronary artery disease",5f491b486d45ecc67f6d3469,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,5 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,193698,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b486d45ecc67f6d3469,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV049-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,495493,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,49,INCOV049-BL-3_TCRB,DNA,Illumina,5f491b496d45ecc67f6d346a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,82,82,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,Remdesivir (RDV), , ,"Chronic hypertension, Chronic kidney disease, Coronary artery disease",5f491b496d45ecc67f6d346a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,3 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,495493,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b496d45ecc67f6d346a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV049-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,511653,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,50,INCOV050-AC-3_TCRB,DNA,Illumina,5f491b4a6d45ecc67f6d346b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,89,89,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,Plasma Transfusions, , ,Malignant neoplasm of the cheek,5f491b4a6d45ecc67f6d346b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,10 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,511653,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b4a6d45ecc67f6d346b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV050-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,624831,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,50,INCOV050-BL-3_TCRB,DNA,Illumina,5f491b4b6d45ecc67f6d346c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,89,89,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,Plasma Transfusions, , ,Malignant neoplasm of the cheek,5f491b4b6d45ecc67f6d346c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,7 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,624831,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b4b6d45ecc67f6d346c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV050-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,258720,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,51,INCOV051-AC-3_TCRB,DNA,Illumina,5f491b4c6d45ecc67f6d346d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,34,34,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Acute,Remdesivir (RDV), , , ,5f491b4c6d45ecc67f6d346d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,4 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,258720,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b4c6d45ecc67f6d346d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV051-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,368731,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,51,INCOV051-BL-3_TCRB,DNA,Illumina,5f491b4d6d45ecc67f6d346e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,34,34,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Baseline,Remdesivir (RDV), , , ,5f491b4d6d45ecc67f6d346e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,2 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,368731,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b4d6d45ecc67f6d346e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV051-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,656089,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,52,INCOV052-AC-3_TCRB,DNA,Illumina,5f491b4e6d45ecc67f6d346f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,89,89,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,Remdesivir (RDV), ,Nasal cannula, ,5f491b4e6d45ecc67f6d346f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,4 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,656089,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b4e6d45ecc67f6d346f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV052-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,619249,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,52,INCOV052-BL-3_TCRB,DNA,Illumina,5f491b4f6d45ecc67f6d3470, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,89,89,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,Remdesivir (RDV), ,Nasal cannula, ,5f491b4f6d45ecc67f6d3470,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,1 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,619249,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b4f6d45ecc67f6d3470,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV052-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,197823,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,53,INCOV053-AC-3_TCRB,DNA,Illumina,5f491b506d45ecc67f6d3471, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,86,86,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Remdesivir (RDV), Tocilizumab, Tocilizumab, Tocilizumab, Acetaminophen", ,Nasal cannula,"Diabetes (Type 2), Chronic hypertension",5f491b506d45ecc67f6d3471,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,8 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,197823,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b506d45ecc67f6d3471,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV053-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,192963,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,53,INCOV053-BL-3_TCRB,DNA,Illumina,5f491b516d45ecc67f6d3472, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,86,86,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Remdesivir (RDV), Tocilizumab, Tocilizumab, Tocilizumab, Acetaminophen", ,Nasal cannula,"Diabetes (Type 2), Chronic hypertension",5f491b516d45ecc67f6d3472,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,6 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,192963,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b516d45ecc67f6d3472,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV053-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,443292,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,54,INCOV054-BL-3_TCRB,DNA,Illumina,5f491b526d45ecc67f6d3473, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,72,72,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,Aspirin, , ,"Diabetes (Type 2), Chronic hypertension",5f491b526d45ecc67f6d3473,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,2 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,443292,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b526d45ecc67f6d3473,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV054-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,694025,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,55,INCOV055-BL-3_TCRB,DNA,Illumina,5f491b536d45ecc67f6d3474, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,67,67,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Acetaminophen, Aspirin", , ,"Diabetes (Type 2), Chronic hypertension, Chronic obstructive pulmonary disease",5f491b536d45ecc67f6d3474,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,10 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,694025,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b536d45ecc67f6d3474,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV055-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,992274,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,56,INCOV056-AC-3_TCRB,DNA,Illumina,5f491b546d45ecc67f6d3475, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,61,61,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f491b546d45ecc67f6d3475,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,992274,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b546d45ecc67f6d3475,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV056-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,853287,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,56,INCOV056-BL-3_TCRB,DNA,Illumina,5f491b556d45ecc67f6d3476, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,61,61,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , , ,5f491b556d45ecc67f6d3476,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,853287,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b556d45ecc67f6d3476,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV056-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,829807,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,57,INCOV057-AC-3_TCRB,DNA,Illumina,5f491b566d45ecc67f6d3477, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,39,39,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , , ,Diabetes (Type 1),5f491b566d45ecc67f6d3477,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,829807,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b566d45ecc67f6d3477,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV057-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,921390,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,57,INCOV057-BL-3_TCRB,DNA,Illumina,5f491b576d45ecc67f6d3478, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,39,39,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , ,Diabetes (Type 1),5f491b576d45ecc67f6d3478,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,921390,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b576d45ecc67f6d3478,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV057-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,490591,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,58,INCOV058-AC-3_TCRB,DNA,Illumina,5f491b586d45ecc67f6d3479, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,63,63,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Aspirin, Acetaminophen", , ,"Carcinoma in situ (breast, ductal, right tubular adenoma of colon), Diabetes (Type 2), Chronic hypertension, Chronic kidney disease, Immunocompromised",5f491b586d45ecc67f6d3479,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,490591,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b586d45ecc67f6d3479,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV058-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,473644,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,58,INCOV058-BL-3_TCRB,DNA,Illumina,5f491b596d45ecc67f6d347a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,63,63,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Aspirin, Acetaminophen", , ,"Carcinoma in situ (breast, ductal, right tubular adenoma of colon), Diabetes (Type 2), Chronic hypertension, Chronic kidney disease, Immunocompromised",5f491b596d45ecc67f6d347a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,473644,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b596d45ecc67f6d347a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV058-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,775323,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,59,INCOV059-AC-3_TCRB,DNA,Illumina,5f491b5a6d45ecc67f6d347b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,82,82,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,Remdesivir (RDV), , ,"Colon cancer, Asthma, Chronic obstructive pulmonary disease",5f491b5a6d45ecc67f6d347b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,10 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,775323,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b5a6d45ecc67f6d347b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV059-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,757629,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,59,INCOV059-BL-3_TCRB,DNA,Illumina,5f491b5b6d45ecc67f6d347c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,82,82,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,Remdesivir (RDV), ,Nasal cannula,"Colon cancer, Asthma, Chronic obstructive pulmonary disease",5f491b5b6d45ecc67f6d347c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,6 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,757629,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b5b6d45ecc67f6d347c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV059-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1041219,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,60,INCOV060-AC-3_TCRB,DNA,Illumina,5f491b5c6d45ecc67f6d347d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,39,39,year,UO:0000036,Sample Collection, ,Unknown Ethnicity,Unknown racial group, , , ,DOID:0080600, ,Acute, , , , ,5f491b5c6d45ecc67f6d347d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1041219,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b5c6d45ecc67f6d347d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV060-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,992642,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,60,INCOV060-BL-3_TCRB,DNA,Illumina,5f491b5d6d45ecc67f6d347e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,39,39,year,UO:0000036,Sample Collection, ,Unknown Ethnicity,Unknown racial group, , , ,DOID:0080600, ,Baseline, , , , ,5f491b5d6d45ecc67f6d347e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,992642,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b5d6d45ecc67f6d347e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV060-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,665839,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,61,INCOV061-AC-3_TCRB,DNA,Illumina,5f491b5e6d45ecc67f6d347f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,61,61,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f491b5e6d45ecc67f6d347f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,665839,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b5e6d45ecc67f6d347f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV061-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,662789,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,61,INCOV061-BL-3_TCRB,DNA,Illumina,5f491b5e6d45ecc67f6d3480, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,61,61,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , , ,5f491b5e6d45ecc67f6d3480,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,662789,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b5e6d45ecc67f6d3480,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV061-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,822079,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,62,INCOV062-AC-3_TCRB,DNA,Illumina,5f491b5f6d45ecc67f6d3481, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,77,77,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Acute,Remdesivir (RDV), ,Nasal cannula,Chronic hypertension,5f491b5f6d45ecc67f6d3481,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,7 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,822079,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b5f6d45ecc67f6d3481,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV062-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,587943,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,62,INCOV062-BL-3_TCRB,DNA,Illumina,5f491b606d45ecc67f6d3482, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,77,77,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Baseline,Remdesivir (RDV), ,Nasal cannula,Chronic hypertension,5f491b606d45ecc67f6d3482,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,4 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,587943,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b606d45ecc67f6d3482,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV062-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,805680,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,63,INCOV063-AC-3_TCRB,DNA,Illumina,5f491b616d45ecc67f6d3483, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,81,81,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , , ,"Asthma, Chronic hypertension, Chronic obstructive pulmonary disease",5f491b616d45ecc67f6d3483,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,805680,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b616d45ecc67f6d3483,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV063-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,739095,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,63,INCOV063-BL-3_TCRB,DNA,Illumina,5f491b626d45ecc67f6d3484, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,81,81,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , ,"Asthma, Chronic hypertension, Chronic obstructive pulmonary disease",5f491b626d45ecc67f6d3484,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,739095,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b626d45ecc67f6d3484,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV063-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,56314,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,64,INCOV064-BL-3_TCRB,DNA,Illumina,5f491b636d45ecc67f6d3485, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,76,76,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,Plasma Transfusions, , ,Chronic hypertension,5f491b636d45ecc67f6d3485,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,2 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,56314,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b636d45ecc67f6d3485,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV064-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,956847,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,66,INCOV066-AC-3_TCRB,DNA,Illumina,5f491b646d45ecc67f6d3486, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,53,53,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f491b646d45ecc67f6d3486,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,956847,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b646d45ecc67f6d3486,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV066-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,787197,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,66,INCOV066-BL-3_TCRB,DNA,Illumina,5f491b656d45ecc67f6d3487, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,53,53,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , , ,5f491b656d45ecc67f6d3487,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,787197,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b656d45ecc67f6d3487,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV066-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,0,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,67,INCOV067-AC-3_TCRB,DNA,Illumina,5f491b666d45ecc67f6d3488, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,41,41,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , , , ,5f491b666d45ecc67f6d3488,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, , ,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b666d45ecc67f6d3488,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV067-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,650015,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,67,INCOV067-BL-3_TCRB,DNA,Illumina,5f491b666d45ecc67f6d3489, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,41,41,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , , ,5f491b666d45ecc67f6d3489,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,650015,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b666d45ecc67f6d3489,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV067-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,854033,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,68,INCOV068-AC-3_TCRB,DNA,Illumina,5f491b686d45ecc67f6d348a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,66,66,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , , ,Liposarcoma,5f491b686d45ecc67f6d348a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,854033,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b686d45ecc67f6d348a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV068-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,702829,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,68,INCOV068-BL-3_TCRB,DNA,Illumina,5f491b686d45ecc67f6d348b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,66,66,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , ,Liposarcoma,5f491b686d45ecc67f6d348b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,702829,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b686d45ecc67f6d348b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV068-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,601449,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,69,INCOV069-AC-3_TCRB,DNA,Illumina,5f491b696d45ecc67f6d348c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,61,61,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , , ,Metastaic papillary adenocarcinoma to lymph node papillary thyroid carcinoma,5f491b696d45ecc67f6d348c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,601449,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b696d45ecc67f6d348c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV069-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,300849,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,69,INCOV069-BL-3_TCRB,DNA,Illumina,5f491b6a6d45ecc67f6d348d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,61,61,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , ,Metastaic papillary adenocarcinoma to lymph node papillary thyroid carcinoma,5f491b6a6d45ecc67f6d348d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,7 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,300849,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b6a6d45ecc67f6d348d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV069-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,228521,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,70,INCOV070-AC-3_TCRB,DNA,Illumina,5f491b6b6d45ecc67f6d348e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,42,42,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Acute,Plasma Transfusions, , , ,5f491b6b6d45ecc67f6d348e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,228521,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b6b6d45ecc67f6d348e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV070-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,163124,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,70,INCOV070-BL-3_TCRB,DNA,Illumina,5f491b6c6d45ecc67f6d348f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,42,42,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Baseline,Plasma Transfusions, ,Mechanical ventilation, ,5f491b6c6d45ecc67f6d348f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,6 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,163124,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b6c6d45ecc67f6d348f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV070-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,193540,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,71,INCOV071-AC-3_TCRB,DNA,Illumina,5f491b6d6d45ecc67f6d3490, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,80,80,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,"Hydroxychloroquine (HCQ), Acetaminophen, Lisinopril (Prinivil)", , ,Congestive heart failure,5f491b6d6d45ecc67f6d3490,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,193540,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b6d6d45ecc67f6d3490,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV071-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,220755,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,71,INCOV071-BL-3_TCRB,DNA,Illumina,5f491b6e6d45ecc67f6d3491, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,80,80,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,"Hydroxychloroquine (HCQ), Acetaminophen, Lisinopril (Prinivil)", ,Nasal cannula,Congestive heart failure,5f491b6e6d45ecc67f6d3491,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,3 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,220755,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b6e6d45ecc67f6d3491,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV071-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,212778,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,72,INCOV072-AC-3_TCRB,DNA,Illumina,5f491b6f6d45ecc67f6d3492, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,84,84,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute,Acetaminophen, , ,"Chronic hypertension, Chronic kidney disease, Chronic obstructive pulmonary disease",5f491b6f6d45ecc67f6d3492,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,212778,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b6f6d45ecc67f6d3492,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV072-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,128925,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,72,INCOV072-BL-3_TCRB,DNA,Illumina,5f491b706d45ecc67f6d3493, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,84,84,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline,Acetaminophen, ,Nasal cannula,"Chronic hypertension, Chronic kidney disease, Chronic obstructive pulmonary disease",5f491b706d45ecc67f6d3493,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,4 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,128925,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b706d45ecc67f6d3493,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV072-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,480344,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,73,INCOV073-AC-3_TCRB,DNA,Illumina,5f491b716d45ecc67f6d3494, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,55,55,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Acute,Naproxen, , , ,5f491b716d45ecc67f6d3494,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,480344,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b716d45ecc67f6d3494,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV073-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,269538,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,73,INCOV073-BL-3_TCRB,DNA,Illumina,5f491b726d45ecc67f6d3495, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,55,55,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Baseline,Naproxen, ,Nasal cannula, ,5f491b726d45ecc67f6d3495,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,8 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,269538,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b726d45ecc67f6d3495,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV073-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,681480,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,74,INCOV074-AC-3_TCRB,DNA,Illumina,5f491b736d45ecc67f6d3496, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,30,30,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , , ,Asthma,5f491b736d45ecc67f6d3496,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,681480,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b736d45ecc67f6d3496,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV074-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,904440,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,74,INCOV074-BL-3_TCRB,DNA,Illumina,5f491b736d45ecc67f6d3497, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,30,30,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , ,Asthma,5f491b736d45ecc67f6d3497,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,904440,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b736d45ecc67f6d3497,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV074-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,160288,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,75,INCOV075-AC-3_TCRB,DNA,Illumina,5f491b746d45ecc67f6d3498, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,57,57,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Acute,Remdesivir (RDV), ,Mechanical ventilation,"Diabetes (Type 2), Chronic hypertension",5f491b746d45ecc67f6d3498,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,4 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,160288,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b746d45ecc67f6d3498,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV075-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,260317,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,75,INCOV075-BL-3_TCRB,DNA,Illumina,5f491b756d45ecc67f6d3499, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,57,57,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Baseline,Remdesivir (RDV), , ,"Diabetes (Type 2), Chronic hypertension",5f491b756d45ecc67f6d3499,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,260317,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b756d45ecc67f6d3499,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV075-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,599254,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,76,INCOV076-AC-3_TCRB,DNA,Illumina,5f491b766d45ecc67f6d349a, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,47,47,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Acute, , , , ,5f491b766d45ecc67f6d349a,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,599254,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b766d45ecc67f6d349a,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV076-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,749125,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,76,INCOV076-BL-3_TCRB,DNA,Illumina,5f491b776d45ecc67f6d349b, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,47,47,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Baseline, , , , ,5f491b776d45ecc67f6d349b,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,749125,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b776d45ecc67f6d349b,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV076-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1049531,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,77,INCOV077-AC-3_TCRB,DNA,Illumina,5f491b786d45ecc67f6d349c, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,51,51,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , , ,"Thyroid cancer s/p thyrodectomy (1999), Asthma",5f491b786d45ecc67f6d349c,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,29 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1049531,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b786d45ecc67f6d349c,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV077-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,807336,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,77,INCOV077-BL-3_TCRB,DNA,Illumina,5f491b796d45ecc67f6d349d, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,51,51,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , ,"Thyroid cancer s/p thyrodectomy (1999), Asthma",5f491b796d45ecc67f6d349d,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,17 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,807336,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b796d45ecc67f6d349d,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV077-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1282636,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,78,INCOV078-AC-3_TCRB,DNA,Illumina,5f491b7a6d45ecc67f6d349e, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,58,58,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Mixed racial group, , , ,DOID:0080600, ,Acute, , , ,"Asthma, Chronic hypertension",5f491b7a6d45ecc67f6d349e,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,38 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1282636,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b7a6d45ecc67f6d349e,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV078-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1166518,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,78,INCOV078-BL-3_TCRB,DNA,Illumina,5f491b7b6d45ecc67f6d349f, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,58,58,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Mixed racial group, , , ,DOID:0080600, ,Baseline, , , ,"Asthma, Chronic hypertension",5f491b7b6d45ecc67f6d349f,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,25 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1166518,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b7b6d45ecc67f6d349f,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV078-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,453767,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,79,INCOV079-AC-3_TCRB,DNA,Illumina,5f491b7c6d45ecc67f6d34a0, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,83,83,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , ,Nasal cannula,"Breast Cancer, Chronic hypertension",5f491b7c6d45ecc67f6d34a0,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,453767,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b7c6d45ecc67f6d34a0,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV079-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,216312,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,79,INCOV079-BL-3_TCRB,DNA,Illumina,5f491b7d6d45ecc67f6d34a1, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,83,83,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , ,Nasal cannula,"Breast Cancer, Chronic hypertension",5f491b7d6d45ecc67f6d34a1,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,216312,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b7d6d45ecc67f6d34a1,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV079-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,402248,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,80,INCOV080-AC-3_TCRB,DNA,Illumina,5f491b7e6d45ecc67f6d34a2, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,66,66,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , ,Nasal cannula,Chronic hypertension,5f491b7e6d45ecc67f6d34a2,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,402248,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b7e6d45ecc67f6d34a2,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV080-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,318977,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,80,INCOV080-BL-3_TCRB,DNA,Illumina,5f491b7f6d45ecc67f6d34a3, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,66,66,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , ,Nasal cannula,Chronic hypertension,5f491b7f6d45ecc67f6d34a3,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,318977,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b7f6d45ecc67f6d34a3,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV080-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1181063,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,81,INCOV081-AC-3_TCRB,DNA,Illumina,5f491b7f6d45ecc67f6d34a4, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,23,23,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Acute, , , , ,5f491b7f6d45ecc67f6d34a4,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1181063,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b7f6d45ecc67f6d34a4,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV081-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1029352,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,81,INCOV081-BL-3_TCRB,DNA,Illumina,5f491b816d45ecc67f6d34a5, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,23,23,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Baseline, , , , ,5f491b816d45ecc67f6d34a5,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1029352,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b816d45ecc67f6d34a5,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV081-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,1084048,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,82,INCOV082-BL-3_TCRB,DNA,Illumina,5f491b826d45ecc67f6d34a6, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,60,60,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , ,Asthma,5f491b826d45ecc67f6d34a6,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,1084048,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b826d45ecc67f6d34a6,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV082-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,733663,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,83,INCOV083-BL-3_TCRB,DNA,Illumina,5f491b836d45ecc67f6d34a7, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,42,42,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , , ,5f491b836d45ecc67f6d34a7,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , , , ,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,733663,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b836d45ecc67f6d34a7,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV083-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,167553,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,84,INCOV084-BL-3_TCRB,DNA,Illumina,5f491b846d45ecc67f6d34a8, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,57,57,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Asian or Pacific Islander, , , ,DOID:0080600, ,Baseline,Acetaminophen, ,Mechanical ventilation,Renal Mass,5f491b846d45ecc67f6d34a8,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,14 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,167553,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b846d45ecc67f6d34a8,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV084-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,631884,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,85,INCOV085-BL-3_TCRB,DNA,Illumina,5f491b846d45ecc67f6d34a9, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,female, ,36,36,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , , ,5f491b846d45ecc67f6d34a9,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,7 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,631884,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b846d45ecc67f6d34a9,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV085-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,97034,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,86,INCOV086-AC-3_TCRB,DNA,Illumina,5f491b856d45ecc67f6d34aa, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,71,71,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Acute, , , ,"Chronic lymphocytic leukemia, Immunocompromised",5f491b856d45ecc67f6d34aa,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,3 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,97034,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b856d45ecc67f6d34aa,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV086-AC-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,35541,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,86,INCOV086-BL-3_TCRB,DNA,Illumina,5f491b866d45ecc67f6d34ab, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,71,71,year,UO:0000036,Sample Collection, ,Non-Hispanic or Latino,Caucasian, , , ,DOID:0080600, ,Baseline, , , ,"Chronic lymphocytic leukemia, Immunocompromised",5f491b866d45ecc67f6d34ab,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,1 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,35541,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b866d45ecc67f6d34ab,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV086-BL-3_TCRB.tsv""]",Adaptive germline database, 
AIRR COVID-19,COVID-19-ISB: A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2.,COVID-19,Case,322261,Adaptive Biotechnologies,blood,TRB, , ,DOI: 10.21417/ADPT2020COVID,ImmuneCODE-COVID-Release-002: COVID-19-ISB,87,INCOV087-BL-3_TCRB,DNA,Illumina,5f491b876d45ecc67f6d34ac, , ,Study,NCIT:C63536,"We describe the establishment and current content of the ImmuneCODE‚Ñ¢ database, which includes hundreds of millions of T-cell Receptor (TCR) sequences from over 1,400 subjects exposed to or infected with the SARSCoV-2 virus, as well as over 135,000 high-confidence SARS-CoV-2-specific TCRs.", ,"Supported by Dept. of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, Biomedical Advanced Research and Development Authority, under Contract No. HHSO100201600031C, by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, by Regione Lombardia, Italy, and by CRIS foundation.","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","1551 Eastlake Ave E, Seattle, WA, US","Adaptive Biotechnologies: Robins, H. hrobins@adaptivebiotech.com","[""contains_tcr""]",,Homo sapiens,NCBITAXON:9606, , ,male, ,56,56,year,UO:0000036,Sample Collection, ,Hispanic or Latino,Unknown racial group, , , ,DOID:0080600, ,Baseline, , , , ,5f491b876d45ecc67f6d34ac,"Whole blood samples were collected in K2EDTA tubes based on each institution‚Äôs protocol and supervised by their respective Institutional Review Board. Samples were stored at the institution and sent to Adaptive as frozen whole blood, isolated PBMC or DNA extracted from either sample type.",UBERON:0000178, , ,2 d,Diagnosis,"Institute for Systems Biology - Whole blood samples collected under the INCOVE project at Providence St. Joseph Health (Seattle, WA). Patients were enrolled during the active phase and monitored through disease", , ,Homo sapiens,NCBITAXON:9606,, , , , , , , , ,PCR,"Immunosequencing of the CDR3 regions of human TCRŒ≤ chains was performed using the immunoSEQ Assay. Extracted genomic DNA was amplified in a bias-controlled multiplex PCR, followed by high-throughput sequencing. The Human-TCRB-PD4bx primer set was used. ",v4,TRBV,TRBJ,partial,nan, ,322261,Adaptive Biotechnologies, , immunoSEQ Assay v4, , , , , , , ,5f491b876d45ecc67f6d34ac,1,"immunoSEQ Assay v4 (Adaptive Biotechnologies, Seattle, WA)", , , , ,"TCRb analysis via the immunoSEQ Assay (Adaptive Biotechnologies, Seattle, WA). Sequences were collapsed and filtered in order to identify and quantitate the absolute abundance of each unique TCRŒ≤ CDR3 region for further analysis. With the author's approval, iReceptor used the the annotated consensus sequence duplicate count (N) to unroll the data so that each consensus sequence count is represented N times in the repository.","[""INCOV087-BL-3_TCRB.tsv""]",Adaptive germline database, 